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Abstract
Rachael S. Wong
Complementary and Alternative Medicine Use 
by Solid Organ Transplant Recipients in the United States
(Under the direction of Ned Brooks)
 Background: Evidence shows that Americans increasingly use complementary and 
alternative medicine (CAM): 36% in 2002, to 38.3% in 2007. Though a significant part of 
received care, it is not considered an integrated component of our health care system in 
literature, practice, or policymaking. Few studies have examined CAM use by the hundreds 
of thousands of solid organ (kidney, pancreas, lung, heart, liver, small bowel) transplant 
recipients in the United States. These individuals often live with chronic medical conditions 
and are high-use patients in our health care system, which invests heavily in transplantation 
as a medical intervention.
 Methods: An online survey program collected self-reported data on CAM use and 
integrative health care (IHC) preferences by U.S. solid organ transplant recipients (reached 
via email requests for participation) in 2010. The survey incorporated 2007 National Health 
Interview Survey CAM questions and IHC questions developed for this study.
 Results: Transplant recipient subjects (n=788) used CAM at a higher rate (56.9%) 
than the general public and most commonly sought CAM for musculoskeletal and mental 
health issues. Higher education and female gender were correlates for CAM use. Nearly half 
(49.7%) integrate their own CAM and medical care although 49.6% want others serving as 
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integrators. Medical doctors ranked highest (46.9%) as desired integrators; trained IHC 
professionals (21.3%) followed.
 Conclusions: This study found that transplant recipients utilize CAM at higher rates 
and for different reasons than the general population, they are willing to share health care 
opinions via online surveys, and additional research is needed to better understand transplant 
recipients’ beliefs and behaviors. There are implications for clinical care, training, research, 
federal policy, and strategic collaborations to improve care and outcomes for transplant 
recipients.  These include recommendations to: 1)  incorporate increasing graft and recipient 
survival rates as a federal transplantation policy goal, 2) provide CAM and IHC training for 
transplant professionals, and 3) plan a strategic initiative to obtain recognition of solid organ 
transplant recipients as a special chronic disease population for inclusion in the rollout of 
patient-centered medical home demonstration projects under the Patient Protection and 
Affordable Care Act of 2010.
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Chapter One - INTRODUCTION
 Evidence shows that Americans are seeking and using complementary and alternative 
medicine (CAM) therapies at increasing rates.1  While CAM represents a significant part of 
the care received in the United States, it is not considered an integrated component of the 
health care system in research, practice, or policymaking.  The purpose of this study is to 
assess CAM use by transplant recipients in the United States—including their reasons for it 
and their preferences for integrative health care (IHC)—and to develop policy 
recommendations based on findings.
 A seminal 1990 study revealed that 34% of 1,539 telephone respondents to a general 
population survey saw at least one CAM provider in the previous year, visits to CAM 
providers outnumbered visits to primary care physicians by 425 million to 388 million, and 
expenses paid for CAM use ($13.7 billion, estimated) were more than the $12.8 billion paid 
out of pocket for all U.S. hospitalizations (Eisenberg, et al., 1993).   The 2002 National 
Health Interview Survey provided a more recent prevalence rate for the general population 
and confirmed that 36% of all adults used at least one CAM therapy during the previous 12 
months (Barnes, Powell-Griner, McFann, & Nahin, 2004).  The 2007 follow-up survey 
showed that CAM use among U.S. adults had grown to 38.3% and that there were increases 
in the use of meditation, yoga, acupuncture, naturopathy, massage and deep breathing 
exercises as CAM therapies (Barnes, Bloom, & Nahin, 2009).  
1 An amended list of CAM terms from the National Center for Health Statistics can be found in Appendix A.
 Integrative medicine (IM) represents the blending of CAM with conventional 
medicine and is acknowledged as a type of allopathic (i.e., traditional, Western medicine) 
practice:  CAM is addressed in at least 75 (of the total of 131) United States medical school 
curricula ("Complementary and Alternative Medicine Courses Taught at U.S. Medical 
Schools," 2007), and 44 U.S. medical schools are members of the Consortium of Academic 
Health Centers for Integrative Medicine ("Consortium of Academic Health Centers for 
Integrative Medicine Members," 2009).  
 Integrative medicine is a “system of healthcare in which conventional medical 
options along with CAM therapies are understood and recommended interdependently, 
depending on the needs of the patient” (Mapping the Emergence of Integrative Medicine: A 
Journey toward a New Medicine, 2003, p. 3).  It emphasizes: 1) relationships, 2) prevention, 
3) patients being active in their own care, and 4) a holistic view of consumers/patients by all 
providers.  Integrative medicine “orients the health care process to create a seamless 
engagement by patients and caregivers in the full range [of] factors known to be effective and 
necessary for the achievement of optimal health over the course of one’s life” (Weisfeld, 
2009).  The term used in this study, “integrative health care” (IHC), represents the philosophy 
of this practice, which is based on a holistic view of health, interdisciplinary teamwork, and 
care broader than the single discipline of medicine alone.
 More recently, CAM and IHC have been recognized as national health research 
priorities.  In June 2009, the Institute of Medicine (IOM) released a report, Initial National 
Priorities for Comparative Effectiveness Research, which lists 100 top priorities for 
comparative effectiveness research under the American Recovery and Reinvestment Act of 
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2009.  In this list, which is divided into quartiles, several priorities are directly related to 
CAM and IHC:
• Compare the effectiveness of mindfulness-based interventions (e.g., yoga, meditation, 
deep breathing training) and usual care in treating anxiety and depression, pain, 
cardiovascular risk factors, and chronic diseases [2nd Quartile].
• Compare the effectiveness of acupuncture for various indications using a cluster 
randomized trial [3rd Quartile].
• Compare the effectiveness of dietary supplements (nutriceuticals) and usual care in 
the treatment of selected high-prevalence conditions [3rd Quartile] (Report Brief: 
Initial National Priorities for Comparative Effectiveness Research, 2009).
Complementary and alternative medicine is a growing part of the care received in the U.S. 
and a topic integral to the discussion of health care reform.  Patients are seeking and 
receiving CAM therapies outside of an imperfect health care system.  Knowledge about why 
people use CAM, what they seek in IHC, and how it might best be formally incorporated in 
the formal health care delivery system will ultimately contribute to the improvement of the 
public’s health.
 In addition to the above-listed priorities, there is also an ongoing need for additional 
research on patient preferences for IHC.  The IOM convened the Summit on Integrative 
Medicine and the Health of the Public in February 2009 to address the role of, value in, and 
next steps for IHC in the United States health care system.  One Summit recommendation 
called for:  “Researchers [to] pursue more in-depth studies of integrative medicine—
specifically, deeper exploration of the various reasons for using integrative medicine; the 
characteristics of patients who express different motivations, including their perceived health 
needs and personal beliefs; and the roles of conventional providers, integrative medicine 
practitioners and patients in integrating treatment” (Bauer-Wu, 2009). 
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 Numerous studies have examined the clinical risks and effects of CAM use for 
various health conditions (Bielory, Russin, & Zuckerman, 2004; Colson & De Broe, 2005; 
Curtis, 2005; Isnard Bagnis, Deray, Baumelou, Le Quintrec, & Vanherweghem, 2004; Kaye, 
Kucera, & Sabar, 2004; Luyckx, 2008; H. MacPherson & Liu, 2005), while others have 
focused on the use of CAM by different patient populations.  Research in the latter is listed in 
Table 1-1.  
Table 1-1. CAM research by patient population
Population/Correlate Studies
People living with HIV/AIDS Agnoletto, Chiaffarino, Nasta, Rossi, & Parazzini, 2006; Cho, Ye, Dobs, & Cofrancesco, 2006.
People living with cancer Lengacher et al., 2002; Steginga, Occhipinti, Gardiner, Yaxley, & Heathcote, 2004; Swarup, Barrett, & Jazieh, 2006; Yates et al., 2005.
People living with fibromyalgia Holdcraft, Assefi, & Buchwald, 2003; Sarac & Gur, 2006; Wahner-Roedler et al., 2005.
People living with pain
(chronic, lower-back, 
musculoskeletal)
Artus, Croft, & Lewis, 2007; Fleming, Rabago, Mundt, & Fleming, 2007; 
Rosenberg et al., 2008; Sherman et al., 2004.
People living with diabetes Bell et al., 2006b; Mehrotra, Bajaj, & Kumar, 2004; Schoenberg, Stoller, Kart, Perzynski, & Chapleski, 2004.
People living with asthma Reznik, Ozuah, Franco, Cohen, & Motlow, 2002; Slader, Reddel, Jenkins, Armour, & Bosnic-Anticevich, 2006.
People living with epilepsy I. J. Kim, Kang, & Lee, 2006; Ricotti & Delanty, 2006; Ryan & Johnson, 2002.
People living with hypertension Amira & Okubadejo, 2007; Bell et al., 2006.
People living with osteoporosis Chong et al., 2007.
People living with sickle cell 
disease
Post-White, Fitzgerald, Hageness, & Sencer, 2009; Sibinga, Shindell, 
Casella, Duggan, & Wilson, 2006.
People living with anxiety Elkins, Rajab, & Marcus, 2005; van der Watt, Laugharne, & Janca, 2008.
People living with multiple 
sclerosis
Campbell et al., 2006; Page, Verhoef, Stebbins, Metz, & Levy, 2003; 
Stuifbergen & Harrison, 2003.
People living with obesity Bertisch, Wee, & McCarthy, 2008.
Surgical patients Norred, 2002; Wang, Caldwell-Andrews, & Kain, 2003.
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Table 1-1. CAM research by patient population
Population/Correlate Studies
Emergency department patients S. Kim et al., 2005; Li, Quinn, McCulloch, Jacobs, & Chan, 2004; Rolniak, Browning, Macleod, & Cockley, 2004.
Residence - by region Gordon & Lin, 2004; Rivera, Ortiz, Lawson, & Verma, 2002.
Residence - urban/rural Cherniack, Senzel, & Pan, 2001; Nichols, Sullivan, Ide, Shreffler-Grant, & Weinert, 2005; Shreffler-Grant, Weinert, Nichols, & Ide, 2005.
Age - older Astin, Pelletier, Marie, & Haskell, 2000; Najm, Reinsch, Hoehler, & Tobis, 2003.
Race
Graham et al., 2005; Mackenzie, Taylor, Bloom, Hufford, & Johnson, 
2003; Mehta, Phillips, Davis, & McCarthy, 2007; Mikhail, Wali, & 
Ziment, 2004; Tanaka, Gryzlak, Zimmerman, Nisly, & Wallace, 2008.
Very few studies, however, have examined the use of CAM by solid organ (kidney, pancreas, 
single- or double-lung, heart, liver, and small bowel) transplant recipients, who now number 
in the hundreds of thousands in the United States.2  Transplant recipients are individuals who 
live with significant chronic health conditions, have undergone major surgery, and are active, 
high-use patients in the U.S. medical system.  The dearth of research on CAM use by this 
population leaves a gap in knowledge about who is using CAM, why they are using it, and 
what they seek in integrative health care.  This third omission is notable because no studies 
have surveyed large sample populations (of any kind) on their preferences related to 
integrative health care (IHC), which is different from CAM and more than just the adding of 
CAM to conventional medicine.   
 The determination of patients’ integrative health care preferences is significant 
because of the overlap between IHC, preventive medicine, and public health, as well as the 
roles these three disciplines play in population health.  As stated in “Preventive Medicine, 
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2 “More than 400,000 organ transplants have been performed in the U.S. over time and it's estimated that at least 
half of them are alive today” (M. Ganikos, personal communication, April 29, 2009).
Integrative Medicine & the Health of the Public”, a paper commissioned for the IOM Summit 
on Integrative Medicine and the Health of Public, the last two share the same three goals—
promotion of general health and well-being, prevention of disease, and use of epidemiology 
techniques to achieve these broad objectives (Katz & Ali, 2009).  Additionally, IHC 
interfaces with preventive medicine to provide patient-centered, interdisciplinary care with a 
focus on health promotion and disease prevention.  This same paper concluded:  “The case 
for integrative [health care] at this juncture in the evolution of health care is persuasive, and 
perhaps nowhere more so than in the zone of overlap with preventive medicine…Given the 
public’s clear and growing interest in CAM, a system of care that fails to address CAM 
simply cannot be patient-centered” (Katz & Ali, 2009).  The identification of patients’ 
integrative health care preferences can contribute to an increasingly patient-centered 
approach to IHC, which in turn supports preventive medicine and public health.
 Information about CAM use and identified IHC preferences by solid organ transplant 
recipients is valuable for both clinical practice and policy development.  This dissertation 
will thus examine the use of CAM in an understudied population to understand why members 
may use CAM and what they seek in IHC.  The logic model for this dissertation is depicted 
in Figure 1-1.
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Purpose
 This study examined the utilization of complementary and alternative medicine 
(CAM) by solid organ transplant recipients in the United States, their reasons for using these 
therapies, and their preferences related to integrative health care (IHC).  My main research 
question was:  What is the use of CAM by solid organ transplant recipients in the United 
States?  Additional sub-questions include:
· What are the correlates, if any, of CAM use in this population? 
· Why are solid organ transplant recipients using CAM?   
· Do solid organ transplant recipients seek IHC, and if so, why? 
Figure 1-1. Dissertation Logic Model
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Definition of terms
 Complementary and Alternative Medicine (CAM) is defined by the National Center 
for Complementary and Alternative Medicine (NCCAM), a division of the National Institutes 
of Health, as “a group of diverse medical and health care systems, practices, and products 
that are not generally considered part of conventional medicine.  Complementary medicine is 
used together with conventional medicine, and alternative medicine is used in place of 
conventional medicine” (The use of complementary and alternative medicine in the United 
States - Fact Sheet, 2008).  An amended list of CAM terms from the National Center for 
Health Statistics can be found in Appendix A.
 Integrative Medicine (IM) is defined by the Academic Consortium for Integrative 
Medicine as “the practice of medicine that reaffirms the importance of the relationship 
between practitioner and patient, focuses on the whole person, is informed by evidence, and 
makes use of all appropriate therapeutic approaches, healthcare professionals and disciplines 
to achieve optimal health and healing” ("Definition of Integrative Medicine," 2009).  It is 
more than just CAM alongside conventional medicine.  Rather it is the holistic practice of all 
types of therapies practiced interdependently with the patient as the focus and part of the 
team.
 Integrative Health Care (IHC) is a broader, more inclusive term than integrative 
medicine, and it “connotes a more equal partnership among all of the actors in the process of 
healing” (Bauer-Wu, 2009).  The acronym is unique to this study.
 Transplant Recipients refers to individuals who have received at least one (1) life-
saving solid organ transplant:  kidney, pancreas, single- or double-lung, heart; liver, and/or 
small bowel.  (Some individuals require subsequent transplants due to graft failure.)  Organs 
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can be donated by living or deceased donors.   As a point of reference:  On November 5, 
2010, there were 109,138 people on the national transplant waiting list.  There were 28,463 
solid organ transplants performed in 2009, with 21,854 of the transplanted organs coming 
from deceased donors ("Organ Procurement and Transplantation Network online database," 
2010).
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Chapter Two - LITERATURE REVIEW
 The chief goal of this review is to describe and assess the literature on CAM use by 
solid organ transplant recipients in the United States.   Additionally, I sought to review 
literature that examined the correlates of CAM usage, the reasons for CAM usage, and 
patient preferences for IHC care. 
 Search Terms.  The MeSH terms, “complementary therapies” and “integrative 
medicine,” were used with “transplant.”
 Sources.  The following five (5) sources were reviewed for this study: 
1. Databases included PubMed (and PubMed CAM Database), PsychINFO, Alt 
HealthWatch, and Alternative Medicine (AMED).  
2. Reference tracking, PubMed “crawling,” and searching through specific journals 
revealed additional articles for review.  
3. Recent IM and CAM conferences provided additional papers and publications.  
4. National IM and CAM academic and research organizations provided reports on 
their websites.  
5. Finally, the release of the National Center for Complementary and Alternative 
Medicine’s report on the 2007 National Health Interview Survey findings resulted 
in articles in daily newspapers and stories on televisions news.
 Article Selection.  Inclusion criteria were that the article had to be published in a peer-
reviewed journal, encompass research designs (i.e., include original data) or literature 
reviews, and include findings on actual CAM use by subjects (versus risks of CAM use or 
clinical/pharmacological effects).  Articles were excluded if the report was not in English or 
did not include solid organ transplant recipients.  Any of the above would have broadened the 
scope of this literature review and strayed from the basic literature review objective.
 Article Coding. The articles were coded by objectives, research design, and findings 
as shown in Table 2-1.
Results
 I conducted an initial PubMed search in June 2009 using the search terms 
“complementary therapies” and “transplant” and which resulted in 46 articles.  Seventeen 
were identified from the abstract as potentially relevant.  A search in PubMed using 
“alternative therapies” and “transplant” did not result in any articles; the 70 cited in a search 
using “alternative” and “transplant” were not relevant. 
 A search in PsychINFO using [“alternative” or “complementary”] with “transplant” 
yielded one (1) article.  A joint search in Alt HealthWatch and AMED using “transplant” and 
“patient” in the title produced 37 articles.  Of these, 35 were excluded for the following 
reasons:  from mainstream/magazine media, focused on clinical alternative therapies, or not 
relevant.  The result was two (2) relevant articles.
 A review of the 17 articles from PubMed, the one (1) article from PsychINFO and the 
two (2) from Alt HealthWatch and AMED revealed duplicate articles.  Only four (4) studies 
on the actual use of CAM by solid organ transplant recipients were found.  A diagram of the 
literature flow based on electronic searches follows in Figure 2-1.
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A summary of the four reviewed articles is listed below in Table 2-1. 
Table 2-1.  Literature Review: CAM Use by Transplant Recipients
Author(s) Year Title Objective(s) Design Sample Findings
Crone & 
Wise
[ALL 
ORGANS]
1997
“Survey of 
alternative 
medicine use 
among organ 
transplant 
patients”
• Document CAM 
use
• Why, source of 
info, perceived 
benefits of 
herbal medicines 
and food 
supplements
• Home/folk 
remedies also 
included
Mailed 
questionnaire to 
all solid organ 
transplant 
candidates and 
recipients at 
transplant 
center
• N = 323 (62% 
of study 
cohort)
• Kidney and 
kidney-
pancreas 
recipients = 
303
• 20% reported use of 
herbal meds or food 
supplements
• Sources: family, 
friends, publications 
(not CAM practitioners 
or salespeople)
• Herbal Reasons: liver 
regeneration, slow 
kidney failure; fatigue; 
insomnia; benefit.
• Vitamin use: some per 
MD; 67% self-
proscribed; sources 
were friends and 
publications; for 
improved health, 
improve immune 
system; enhance organ 
function.  Side effects 
noted.
Figure 2-1. Literature Search and Review Summary
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Table 2-1.  Literature Review: CAM Use by Transplant Recipients
Author(s) Year Title Objective(s) Design Sample Findings
Hess, et al. 
[KIDNEY] 2008
“Prevalence and 
correlates of 
selected 
alternative and 
complementary 
medicine in 
adult renal 
transplant 
patients”
• Document CAM 
use (i.e., 
prevalence and 
correlates)
• Cross-
sectional 
study using 
SMART data 
and written 
self-
reporting of 
CAM use
• Measured: 
comorbidities 
present; 
depression; 
smoking 
• N = 356 
kidney 
recipients 
(86%)
• At least one 
year post-tx
• 2 outpt 
SWISS clinics
• 11% use CAM
• Homeopathy (42.9%) 
and Chinese medicine 
(23.8%) most used
• Paralleled general 
Swiss population but 
younger age.
Matthees, 
et al. 
[LUNG]
2001
“Use of 
complementary 
therapies, 
adherence and 
quality of life in 
lung transplant 
recipients”
• Document CAM 
use
• What used, why 
used, cost, 
communication 
of
• Adherence 
• Quality of life
Mailed survey 
(based on 
Eisenberg 
survey)
• N = 99 (68%)
• Lung & heart-
lung recipients
• 88% use CAM
• Prayer, support groups 
and relaxation used 
most
• Only 44% told 
provider
• CAM users “were 
adherent to their 
transplant regimen”.
• Few differences 
between users and 
non-users
• Correlates w/
education, symptom 
burden, female and 
depression
Tickerhoff, 
Wagner, 
Cacciarelli 
& Singh
[LIVER]
2006
“Alternative 
therapy use in 
liver transplant 
patients”
• Document CAM 
use
• Associated 
psychosocial 
and behavioral 
factors
• Associated QoL 
and health 
beliefs
Questionnaire 
administered by 
transplant nurse
• N = 55
• Liver 
recipients
• All male 
veterans
• 34.4% use CAM
• 45% use herbs
• Users have greater 
problem coping skills
• 19% spend >$100/year
• Spending more 
correlates w/ better 
health, employed
 Crone and Wise (1997) surveyed 323 organ transplant candidates3 and recipients in a 
U.S. transplant program and found that 20% used herbal medicines and/or health food 
supplements.  The primary investigator’s “interest in [this study] was originally spurred by 
patients telling me about supplements they were taking but had not necessarily told the 
13
3 A “transplant candidate” is a person who is registered on the national waiting list for a life-saving organ 
transplant.
transplant team about and they were often particularly hesitant to tell their transplant doc[tor] 
about them” (C.C. Crone, personal communication, June 30, 2009).  
 Mathees et al. (2001) found in a mailed survey of 99 lung transplant recipients that 
88% had used at least one CAM modality (e.g., mind-body therapies; manipulative therapies, 
prayer, vitamins and supplements, and other therapies), with prayer (68%), support groups 
(43%) and relaxation techniques (31%) the most frequently 
used.  Tickerhoof et al. (2006) surveyed 32 liver transplant 
recipients on their use of CAM therapies and found that more 
than a third (35%) used at least one type of therapy after 
transplantation.  Outside of the United States, Hess et al. 
(2008) examined the prevalence and correlates of selected 
CAM therapies in adult renal transplant patients in Switzerland 
and found 11% used at least one CAM therapy, with 
homeopathy (43%) and Chinese medicine (24%) the most popular therapies among users.  
 The above four studies all sought to determine the prevalence of CAM use by solid 
organ transplant recipients and looked at different correlates.  Crone and Wise (1997) also 
examined [ALL ORGANS] patients’ sources of information about two CAM categories and 
their perceived benefits of these therapies: vitamin/mineral supplements and herbal medicine/
health food supplements.  Of the 64 patients taking herbal medicine or health food 
supplements, most received decision-making information from family, friends and nutrition 
publications; 78% felt the therapy was of personal benefit.  For the 15 patients taking 
vitamin/mineral supplements, decision-making information came primarily from nutrition 
Note:  In order to help the 
reader distinguish between 
these four studies 
throughout this chapter, 
Crone and Wise (1997) will 
be tagged as [ALL 
ORGANS] in future 
references.  Mathees et al. 
(2001) will be marked as 
[LUNG], with Tickerhoof et 
al. (2006) as [LIVER] and 
Hess et al. (2008) as 
[KIDNEY].
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publications, friends and physicians, and perceived benefit was mixed—33% saw a benefit 
and 10% either did not see a benefit or were not sure if there was a benefit.
 Other studies of transplant recipients examined correlates of CAM use.  Mathees et 
al. (2001) researched [LUNG] patient communication of CAM use to medical providers and 
found that only half of them (44%) discussed their CAM use with medical providers.  
Tickerhoof et al. (2006) assessed the psychosocial, behavioral, and quality of life correlates 
with CAM use and found that [LIVER] patients who incurred out-of-pocket expenses for 
CAM tended to be employed, reported better overall health, and had higher mastery skills 
that indicate greater personal control.  Finally, Hess et al. (2008) sought to determine the 
correlates of CAM use by [KIDNEY] transplant patients and found that female and younger 
patients were more likely to use CAM therapies.
Discussion
 These four studies represent the existing research on solid organ transplant recipient 
use of CAM therapies.  While these studies provide valuable information, there are 
limitations, including:  no consistent definition of CAM used across studies (Hess, De Geest, 
Halter, Dickenmann, & Denhaerynck, 2009); small and/or specific (e.g., inpatient male 
veterans) sample populations (Matthees, et al., 2001); and inherent weakness in using self-
reporting as a data collection method (Crone & Wise, 1997).  
 These four articles covered several of the topics of focus in CAM and IHC research:  
correlates of CAM use; cost of CAM use; communication of CAM use with conventional 
medical providers; and adherence to medical regimen with CAM use.  Small sample sizes 
(acknowledged by authors), non-representative samples, and lack of consistent definitions of 
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CAM, however, limit the applicability of the above findings.  A broader understanding of 
how CAM use by transplant recipients fits into the larger context of CAM and IHC 
knowledge is necessary to appropriately expand upon existing research and address this 
study’s research objectives.  The next three sections—Correlates of CAM Use, Reasons for 
CAM Use, and Patient Preferences in IHC—will describe what was found in the literature 
review for each research topic,  provide an overview of findings for CAM and other 
populations, and highlight the relevance for transplant recipient research.
Correlates of CAM Use
 CAM use appears to be higher among women, younger people, and more educated 
patients.  Crone and Wise (1997) did not examine correlates of CAM use by the [ALL 
ORGANS] transplant patients in their study.   Matthees et al. (2001) noted few significant 
differences between their study’s [LUNG] transplant recipients (n=99) who used CAM and 
those who did not, although higher education level and female gender did correlate with the 
use of certain CAM therapies.  Tickerhoof et al. (2006) also did not find any significant 
differences between CAM users and non-users in their sample of [LIVER] transplant 
recipients (n=32) for variables such as race, education, income, marital status and housing.  
Patients with higher mastery of coping skills were more inclined to use CAM therapies, but 
this factor is not a standard variable measured in CAM use research.  Finally, Hess et al. 
(2008) noted that CAM users in their Swiss adult [KIDNEY] transplant recipient sample 
(n=356) were younger in age and more likely to be female than non-users.   This summarizes 
findings on correlates to CAM use in the transplant recipient population.  Significant 
correlates have been determined in both general and specific population studies.
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 Within the field of CAM research among the general population, there have been two 
large-scale replicated studies that have provided benchmark data for CAM use.  The first was 
by David Eisenberg and colleagues from Harvard Medical School in 1990.  They conducted a 
telephone survey of 1,539 nationally-representative households measuring adult use of CAM 
therapies to determine prevalence, cost, and patterns (Eisenberg, et al., 1993).  This survey 
garnered national mainstream media attention because it shed light on the widespread use of 
CAM therapies by Americans.   A follow-up 1997 study of 2,055 adults allowed for 
comparisons, trend analysis, and the collection of added data such as disclosure of CAM use 
to conventional medical providers (Eisenberg, et al., 1998).  
 The second study on a larger general population was conducted by the National 
Center for Complementary and Alternative Medicine (part of the National Institutes of 
Health).  It added a component to the National Health Interview Survey (NHIS) conducted in 
2002 and 2007.  These two surveys included interviews of 31,044 (2002) and 23,393 (2007) 
adults ages 18 years and older, as well as children (Barnes PM, 2008).  [For the purposes of 
this study, only findings from adult respondents will be covered.]
 Eisenberg (1993) identified the following correlates of CAM usage:  age (25-49 
years); non-black race; higher (some college or above) level of education; higher income (>
$35,000); and living in the West.  No significant differences were found with the variables of 
gender and insurance coverage.  In 1997, female gender was the only new positive correlate 
of CAM use.  Significant correlates from the previous survey were consistent:  non-African 
American race; age (35-49 years); education (at least some college) level; income (>
$50,000); and living in the West (Eisenberg, et al., 1998).  
17
 The 2002 and 2007 NHIS surveys also revealed many of the same positive correlates 
for CAM use:  female gender, age (30-69 years old), higher education levels, not poor, 
former smoker, living in the West, recent hospitalization(s), number of health conditions, 
private health insurance coverage (for those under age 65 only), number of physician visits, 
worry about cost causing the delay in receiving conventional medicine, and inability to afford 
conventional medicine (Barnes PM, 2008).  It should be noted that the 2002 survey included 
prayer—for one’s own health, by others for one’s health, and in groups—as a CAM modality 
and the later survey did not.  In the first NHIS survey, user characteristics of the CAM 
grouping of mind-body therapies significantly changed based on whether prayer was 
included or excluded in the analysis.  Table 2-2 is a visual representation of the comparable 
correlates of CAM usage found in these four national surveys, with prayer excluded from the 
2002 NHIS findings.
Table 2-2. Positive correlates of CAM use among U.S. adults in four national studies
Eisenberg (1991) Eisenberg (1997) NHIS (2002) NHIS (2007)
1. Gender None Female Female Female
2. Age 25-49 y.o. 35-49 y.o. 30-69 y.o. 30-69 y.o.
3. Race Non-black Non-African American Varied by therapy None
4. Income >$35,000 >$50,000 Not poor* Not poor*
5. Education Some college or more Some college or more More than high school More than high school
6. Residence Living in the West** Living in the West** Living in the West** Living in the West**
7. Smoking 
history N/A N/A Former smoker Former smoker
8. Hospitalization N/A N/A Hospitalized in last year Hospitalized in last year
9. # of Doctor 
Visits N/A N/A Greater number Greater number
10.  # of Health 
Conditions N/A N/A Greater number Greater number
*Family income > poverty threshold           **WA, OR, CA, NV, NM, AZ, ID, UT, CO, MT, WY, AK, and HI
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 The above list includes 10 correlates positively associated with CAM users in the four 
large replicated national surveys of CAM use.  Conboy et al. (2005), however, conducted a 
literature review of studies that explored relationships between CAM use and social 
determinants and found that correlates vary by the type of CAM therapy for the first five 
correlates listed in Table 2.   This variety is captured in Table 2-3.
Table 2-3.   Example of the range of results from Medline®-indexed studies examining relationships 
between selected social factors and CAM use (Conboy, et al., 2005)
Social 
determinant Trend in CAM use References
Age Younger people more likely to 
use CAM
Adler, 1999; Boon et al., 2000; Gotay, 1999; Kelner & Wellman, 1997; 
MacLeanna et al., 1996; Nicassio et al. 1997; Oneschuk et al., 1998; 
Ostrow et al., 1997, van der Zouwe et al. 1994
Middle-age people more likely 
to use CAM
Blais et al., 1997; Eisenberg et al., 1993a, 1998; Kitai et al., 1998; Millar, 
1997
Older people more likely to use 
CAM
Krastins et al., 1998
No effect of age Astin, 1998; Krauss et al., 1998
Gender Women use more CAM Boon, et al., 2000; Burg et al., 1998; Eisenberg et al., 1998; Gotay, 1999; 
Kelner & Wellman, 1997; Macintyre, 1992; MacLennan et al., 1996; 
Millar, 1997
No effect of gender Astin, 1998; Blais et al., 1997; Eisenberg et al., 1993a; Kitai et al., 1998; 
Krauss et al., 1998
SES: income, 
education, and 
class
Use associated with higher 
income
Blais et al., Eisenberg et al., 1993a, 1998; Kennedy, 1992; Krastins et al., 
1998; Lerner & Krauss, 1998; MacLennan et al., 1996; Miller, 1997; 
Ostrow et al., 1997
Use associated with higher 
education
Astin, 1998; Burg et al., 1998; Eisenberg et al., 1993a,b; Evans, 1999; 
Gotay, 1999; Houston & Valentine, 1998; Krastins et al., 1998; 
MacLennan et al., 1996; Millar, 1997; Schimpff, 1997; Wolsko et al., 
2000; Singh et al., 1996; van der Zouwe et al., 1994
Use associated with higher 
social class
Hemminski et al., 1991
Use not associated with higher 
income
Singh et al., 1996
Use not associated with higher 
education
Singh et al., 1996
Marital status Use is higher for coupled 
individuals
Risberg et al., 1995
No difference by marital status Furnham & Smith, 1988; Furnham & Bhagrath, 1993; Furnham & Forey, 
1994; Furnham & Kirkcaly, 1996; Sato et al., 1995
Racial/ethnic 
differences in use
Significant effect of race or 
ethnicity
Burg et al., 1998; Eisenberg et al., 1993a; Eisenberg et al, 1998; Kelner & 
WEllman, 1997; MacLennan et al., 1996
No effect of race or ethnicity Elder et al., 1997; Kelner & Wellman 1997; Kitai et al., 1998; Krauss et al., 
1998; Liu et al., 2000; Rawsthorne et al, 1999; Singh et al., 1996
              CAM, complementary and alternative medicine:  SES, socioeconomic status
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 Other studies examined specific populations (e.g., by race, age, health condition, and 
place of residence) and found additional correlates for CAM use.  These include:  race 
(Dente, Herman, Allen, & Hunt, 2006), number of severe experienced symptoms 
(Fouladbakhsh, Stommel, Given, & Given, 2005), use of over-the-counter and prescription 
medications (Gardiner, et al., 2007), openness to experience, perceived friend support, and 
perceived partner and family strain (Honda & Jacobson, 2005), past CAM use and belief in 
safety of CAM use (I. J. Kim, Kang, & Lee, 2006), seeking of “optimum treatment” and 
desire to stop taking certain medications (Langhorst, et al., 2005), perceived quality of care, 
social use and recommendations, dissatisfaction with cost, waiting time for conventional 
medical care, and adherence to traditional health beliefs (Lee, Charn, Chew, & Ng, 2004), 
acculturation factors and church attendance (Loera, Reyes-Ortiz, & Kuo, 2007), and 
paranormal beliefs (Van den Bulck & Custers, 2009).   Table 2-4 provides a listing of studies 
that examined the correlates of CAM use in different populations and shows that most of the 
studied categories correspond with the NHIS fields.
Table 2-4.  Literature Review: Correlates with CAM usage in specific population studies
Author(s) Year Title Findings
Dente, J. M., C. 
J. Herman et al. 2006
“Ethnic differences in 
the use of 
complementary and 
alternative therapies 
among adults with 
osteoarthritis"
• The Hispanic (n = 218) and non-Hispanic white (n = 204) 
populations showed similar rates of overall current CAM use 
(65.5% Hispanic vs 67.8% NHW) at time of interview. 
• However, although more Hispanics used oral herbs (P = .03) and 
magnets or copper jewelry (P = .03), more non-Hispanic whites 
used nutritional supplements (P < .001). 
• Hispanics speaking primarily English mirrored patterns of CAM 
use among non-Hispanic whites
Fouladbakhsh, J. 
M., M. Stommel 
et al.
2005
"Predictors of use of 
complementary and 
alternative therapies 
among patients with 
cancer"
Significant predictors of CAM use were gender, marital status, 
cancer stage, cancer treatment, and number of severe symptoms 
experienced. 
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Table 2-4.  Literature Review: Correlates with CAM usage in specific population studies
Author(s) Year Title Findings
Gardiner, P., R. 
Graham et al. 2007
"Factors associated 
with herbal therapy 
use by adults in the 
United States" 
Correlates with herb use:
• age (45-64 years old),
• lack of insurance,
• gender (female),
• geographic region (living in the West),
• higher education,
• use of medications (prescriptive or over-the-counter),
• race (non-Hispanic other), and
• uninsured, being female, having a higher education, living in the 
West. 
Most commonly-used herbs:  echinacea (41%), ginseng (25%), 
gingko (22%), and garlic (20%). 
Reasons:  head or chest cold (30%), musculoskeletal conditions 
(16%), and stomach or intestinal illness (11%). 
Honda, K. and J. 
S. Jacobson 2005
“Use of 
complementary and 
alternative medicine 
among United States 
adults: the influences 
of personality, coping 
strategies, and social 
support"
The following correlates w/ CAM use were determined:
• Openness -  positively associated (except for manipulative body-
based methods). 
• Extroversion - inversely correlated with mind-body therapy use. 
• Primary control - inversely correlated
• Secondary control - correlated. 
• Perceived friend support - positively associated with manipulative 
body-based methods, mind-body therapies, and alternative 
medical systems. 
• Perceived partner strain - positively associated with biologically 
based therapy use. 
Kim, I. J., J. K. 
Kang et al. 2006
"Factors contributing 
to the use of 
complementary and 
alternative medicine 
by people with 
epilepsy"
CAM use in the past was independently related to gender, economic 
status, and a belief in the safety of CAM use, whereas CAM use in 
the near future was independently associated with experience with 
CAM use in the past and a belief in the safety of CAM use.
Langhorst, J., I. 
B. Anthonisen et 
al.
2005
"Amount of systemic 
steroid medication is a 
strong predictor for the 
use of complementary 
and alternative 
medicine in patients 
with inflammatory 
bowel disease: results 
from a German 
national survey" 
• Total of 671 adult respondents, of which 344 (51.3%) had 
experience with CAM.  Significant: more ulcerative colitis 
patients (59.8%) than the Crohn's disease patients (48.3%) had 
used CAM. 
• Most common types: Homeopathy (52.9%) and herbal medicine 
(43.6%). 
• Reasons:  seeking "optimum treatment" (78.9%) and the wish to 
stop taking steroids (63.8%). Significant: total cortisone intake 
(not disease duration) = strong predictor of use. 
Lee, G. B., T. C. 
Charn et al. 2004
"Complementary and 
alternative medicine 
use in patients with 
chronic diseases in 
primary care is 
associated with 
perceived quality of 
care and cultural 
beliefs"
• Factors associated with CAM use: “middle age, arthritis, 
musculoskeletal disorders and stroke, multiple conditions, poor 
perceived health, family use of CAM, recommendation by close 
social contacts, strong adherence to traditional health beliefs, and 
perceived satisfaction with care.” 
• Patients dissatisfied with cost of treatment and waiting time more 
likely to use CAM; overall care satisfaction correlated with less 
CAM use.
• Satisfaction with doctor-patient interaction was not associated 
with CAM use.
Loera, J. A., C. 
Reyes-Ortiz et al. 2007
"Predictors of 
complementary and 
alternative medicine 
use among older 
Mexican Americans"
Potential predictors of CAM use:
• Sociodemographics (female, Medicaid coverage, church 
attendance),
• acculturation factors (not being born in the US), and
• medical conditions (higher number of comorbidities). 
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Table 2-4.  Literature Review: Correlates with CAM usage in specific population studies
Author(s) Year Title Findings
Upchurch, D. M., 
L. Chyu et al. 2007
"Complementary and 
alternative medicine 
use among American 
women: findings from 
The National Health 
Interview Survey, 
2002"
• Not many differences between women using different CAM 
therapies.
• Some differences between those who used CAM and those who 
prayed for health.
• Reasons for CAM use: treat common pain.
• Also: women often reported using CAM alongside conventional 
medicine.
Van den Bulck, J. 
and K. Custers 2009
"Belief in 
complementary and 
alternative medicine is 
related to age and 
paranormal beliefs in 
adults" 
CAM beliefs were strongly associated with paranormal beliefs.
It is apparent that the correlates of CAM use are not a distinct, neat group and that sample 
populations’ circumstances and types of used CAM therapies play different roles.   For 
example, Fouladbakhsh et al. (2005) found that significant predictors of CAM use for people 
living with cancer were gender, marital status, cancer stage, cancer treatment, and number of 
severe symptoms.  In contrast, Kim et al. (2006) identified gender, economic status, and 
belief in safety of CAM use as the correlates for CAM use by people living with epilepsy.  
While many correlates of CAM use do emerge from studies examining different populations, 
several are clearly relevant to the transplant community.  
 Reflecting this review, this study collected demographic information on age, gender, 
race, income, education, and residence [the first six (6) correlates in Table 2-2] to make 
findings comparable to the general population as well as smaller, specific population studies.  
This review shows that:  the NHIS instrument does a good job of covering domains found in 
other existing literature, use of the same response categories will allow for comparability 
across general and specific populations, and replication of the NHIS CAM component 
addressed this study’s primary research question (What is the use of CAM by solid organ 
transplant recipients in the United States?) as well as the first two sub-questions (What are 
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the correlates, if any, of CAM use in this population? and Why are solid organ transplant 
recipients using CAM?).
Reasons for CAM Use
 Research on the reasons transplant recipients seek and use CAM therapies is scarce.  
Crone and Wise (1997) asked the 323 [ALL ORGANS] recipients for the reason(s) they took 
vitamins and herbal supplements.  The top reasons (with the number of responses in 
parentheses) provided by the 15 transplant recipient respondents who took vitamins were: 
general health (7), reduce colds/infections (6), reduce bone loss (4), for specific organs (i.e., 
heart, eyes) (4), and “toxicity” (3).  The top reasons provided by the 64 herbal medicine/
health food supplement users were:  boost energy (6), liver regeneration (7), prolong kidney 
function (4), sleep (5), and general health (4).  
 Matthees et al. (2001) also found that [LUNG] recipients shared varied reasons for 
CAM use.  The 99 lung recipient respondents listed the following reasons (reprinted from p. 
264):  
Mind-body therapies:  Seeking relief from anxiety, stress, depression and/or 
fatigue, to promote improved breathing, maintenance of flexibility (yoga), overall 
health
Manipulative therapies: For relief of stress or cramps, pain in the shoulder, hips, 
neck, back, head
Prayer:  To deal with “daily concerns,” “everything, everyday life,” health, “a 
lot of little things,” any time and through prayers lists at church; to alleviate 
anxiety, stress, tension, sadness, depression; 2 patients listed physical complaints 
(backaches, soreness)
Support groups: Generally because of lung disease issues; 3 patients reported 
attending to “help others” or for personal “moral support”
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Biologically based:  To combat weight gain or loss, for overall good health 
(multivitamins, some using calcium as well), for “keeping the immune system 
healthy”, fatigue, osteoporosis; ginkgo biloba used to combat memory loss; 
Replenix and glucosamine used for joints
Tickerhoof et al. (2006) and Hess et al. (2008) did not ask [LIVER] and [KIDNEY] subjects for 
their reasons for CAM use.   The scant research on why transplant recipients use CAM 
therapies reveals disparate reasons, and this study sought to build upon existing knowledge 
about this specific population on a larger scale.
 Numerous studies have, however, examined the reasons for CAM use by other 
populations.  Astin (1998) conducted a national study of 1,035 subjects who responded to 
mailed surveys that asked them about CAM use, perceived benefits and risks of use, views 
and experiences toward conventional medicine, and health beliefs and attitudes, and he found 
that motivation for using CAM was not dissatisfaction with conventional medicine.  Rather, 
CAM fits into users’ own experiences, values, and beliefs about life and health.  Reasons for 
CAM use include poorer health status and health problems (e.g., anxiety, back problems, 
chronic pain, and urinary tract problems). They also extend to a holistic orientation to health, 
self-identification with groups committed to issues/philosophies (like environmentalism and 
feminism), and transformational life experiences.  
 Other studies identified additional reasons for CAM use, depending on the sample 
population and setting.  These include:  desire for general health counseling, dietary and 
nutritional treatment, and “increased self-insight and benefit from a wider perspective of 
healing” (D'Crus & Wilkinson, 2005), relief from pain and stress, as well as relaxation 
(Emslie, Campbell, & Walker, 2002), desire for self control (Hedderson, et al., 2004), 
dissatisfaction with conventional medical provider (Hedderson, et al., 2004; Sirois & Purc-
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Stephenson, 2008a), treatment and prevention of disease, overall health, and helpfulness of 
CAM therapies (Kessler, et al., 2001), openness to trying new things (Sirois & Gick, 2002; 
Sirois & Purc-Stephenson, 2008b; Smith, et al., 2008), egalitarian provider preference (Sirois 
& Purc-Stephenson, 2008a), and the “appealing, less invasive, and less druglike” qualities of 
CAM therapies as compared to conventional medicine (Swartzman, Harshman, Burkell, & 
Lundy, 2002).  These findings are described in greater detail in Table 2-5.
Table 2-5.  Literature Review:  Reasons for CAM use
Author(s) Year Title Findings
Astin 1998
“Why patients use 
alternative medicine: 
results of a national 
study”
• Increased use: “more education; poorer health status; a 
holistic orientation to health; having had a transformational 
experience that changed the person’s worldview; any of the 
following health problems: 
• anxiety
• back problems
• chronic pain
• urinary tract problems; and
• classification in a cultural group identifiable by their 
commitment to environmentalism, commitment to 
feminism, and interest in spirituality and personal 
growth psychology. 
• Dissatisfaction with conventional medicine did not predict 
use of alternative medicine. 
• Only 4.4% of those surveyed reported relying primarily on 
alternative therapies.”
D'Crus, A. and J. M. 
Wilkinson 2005
"Reasons for choosing 
and complying with 
complementary health 
care: an in-house study 
on a South Australian 
clinic"
• Most frequent reasons:  desire for general health counseling 
(54%) and dietary and nutritional treatment (50%).
• 36% “sought increased self-insight and benefit from a wider 
perspective of healing.”
• 55% think quality of relationship with CAM provider “has a 
major impact on compliance and continuity of treatment” 
that relates to success of treatment.
Emslie, M. J., M. K. 
Campbell et al. 2002
"Changes in public 
awareness of, attitudes 
to, and use of 
complementary therapy 
in North East Scotland: 
surveys in 1993 and 
1999"
The self-reported primary reasons for using CAM were relief 
of pain due to headaches or musculoskeletal problems, for 
relaxation, and relief of stress.
Hedderson, M. M., 
R. E. Patterson et al. 2004
"Sex differences in 
motives for use of 
complementary and 
alternative medicine 
among cancer patients"
• CAM use positively associated with: desire for personal 
control across sexes. 
• “High cancer related symptom distress score and 
dissatisfaction with a conventional provider predicted 
increased dietary supplement use for men, but decreased 
dietary supplement use for women.”
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Table 2-5.  Literature Review:  Reasons for CAM use
Author(s) Year Title Findings
Kessler, R. C., R. B. 
Davis et al. 2001
"Long-term trends in 
the use of 
complementary and 
alternative medical 
therapies in the United 
States"
• 49.7% Michigan adults had used at least one CAM therapy 
in the last 12 months
• Most common: supplements (20.5%), special diets (12.6%), 
chiropractic care (12.2%), and other (nonvitamin, 
nonherbal) dietary supplements (10.8%).
• Discussed with PCP (45.9%).
• Reasons: to treat a disease (24.4%), to prevent a disease 
(6.8%), to promote overall health (42.5%), found all CAM 
therapies helpful (83.2%), and found some helpful (5.8%).
Sirois, F. M. and M. 
L. Gick 2002
"An investigation of the 
health beliefs and 
motivations of 
complementary 
medicine clients"
• Best predictors of overall and new, infrequent CAM use: 
“health-aware behaviors” and dissatisfaction with 
conventional medicine
• Other predictors of different kinds of CAM use:  medical 
need, openness to new experience, and income.
Sirois, F. M. and R. 
J. Purc-Stephenson 2008
"Personality and 
consultations with 
complementary and 
alternative medicine 
practitioners: a five-
factor model 
investigation of the 
degree of use and 
motives"
• Correlates:  Openness and Agreeableness consistently 
linked to different dimensions of CAM use, especially 
homeopathy and naturopathy. 
• Openness associated with variety of tried CAM providers v. 
Agreeableness linked to breadth and frequency of CAM 
visits. 
• Holistic and proactive health motivations associated with 
personality factors; Agreeableness also associated with 
motives for desire for shared decision-making.
Sirois, F. M. and R. 
J. Purc-Stephenson 2008
"Consumer decision 
factors for initial and 
long-term use of 
complementary and 
alternative medicine"
• Correlates consistent with model:  age, social 
recommendations, symptom severity, egalitarian provider 
preference, and dissatisfaction with conventional care.
• Connected to pattern and frequency of CAM use.
Smith, B. W., J. 
Dalen et al. 2008
"Who is willing to use 
complementary and 
alternative medicine?"
• Strongest predictors: openness to experience, spirituality, 
and mood attention.
• For mind-body medicines: older age, and female gender.
• For curanderismo, Hispanic race; for Native American 
medicine and spiritual/faith healers, Native American race.
Swartzman, 
Harshman, Burkell 
& Lundy
2002
“What accounts for the 
appeal of 
complementary/
alternative medicine, 
and what makes 
complementary/
alternative 
‘alternative’?”
• Five factors measured: distinction between conventional 
and CAM, treatment appeal, invasiveness, health care 
professional v. patient effort, and “druglikeness”.
• CAM treatments were seen as more “appealing, less 
invasive, and less druglike” than conventional medicine, 
with emphasis on it being less invasive.
 This review shows that the reasons for using CAM therapies fall across a broad 
spectrum and vary according to patient population and circumstance.  The relevance to 
research with transplant recipients is clear because it is valuable to learn whether the reasons 
for CAM use by this specific population correlate with those from other chronic disease 
populations, if recipient characteristics (e.g., length of time since transplant surgery or type of 
organ) make a difference, and whether primary reasons are due to physical/mental health 
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symptoms or are philosophical in nature.  Transplant recipients are an ideal population to 
study because they are high users of the health care system, often live with multiple 
comorbidities, and have experienced a broad spectrum of health conditions.  They also 
represent one of the few populations that has faced chronic, serious (i.e., near-terminal) 
illness and reversed that trajectory of health.  Their reasons for CAM use and IHC 
preferences provide insights related to the needs of others served by the U.S. health care 
system.
Patient Preferences for Integrative Health Care
 None of the four studies that examined CAM use by transplant recipients addressed 
subjects’ IHC preferences, thereby confirming the need for investigation into this topic.  In 
fact, although many patients seek the more holistic approach to health care (Astin, 1998) that 
IHC represents, very little research is dedicated to this topic and instead touches more on 
patient satisfaction with IHC. 
 Three studies examined what IHC patients believe about IHC, its important elements, 
and their satisfaction with it.  McCaffrey, Pugh and O’Connor (2007) sought to find out what 
motivates people to opt for IHC (described as integrative medicine/IM in this study) for their 
primary care needs and collected qualitative data through focus groups.  They found that 
patients prefer to discuss their CAM use with their physicians and obtain guidance on these 
therapies, their health needs are not being met by conventional medicine, and they seek more 
time with providers and shared decision-making. 
 The 37 participants were all regular users of IHC (patients at IHC clinics) and 
expressed the following beliefs about IHC (reprinted from p. 1502):
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• Combined approach of CAM and conventional medicine provides better care than 
either approach alone
• Health and well-being are a combination of physical health, emotional health, 
lifestyle, and spirituality
• Nutrition and supplements are important to health
• Avoid prescription medicine except as last resort
Focus group members also identified the following important elements in the patient-
provider encounters in IHC (p. 1502):
• Openness to CAM use
• New framework for understanding symptoms and new treatment options
• Time with their provider
• Feeling listened to by their provider
• Opportunities for shared decision-making
• Health insurance coverage for the encounter
 Two other studies confirm these findings.  Koithan, Bell et al. (2007) retrospectively 
analyzed transcripts of cancer and non-cancer IHC patient focus groups and found that 
patients were very satisfied with IHC (also described as integrative medicine/IM in this 
study) care.  Reasons include:  broadening of options for treatment, less perceived toxicity of 
treatment as compared to conventional medicine, IHC physicians taking time to listen, 
providers’ caring approach made for positive experiences, and increased feeling of 
empowerment and better self-care skills.  
 Myklebust, Pradhan et al. (2008) conducted a prospective patient survey at a 
Michigan IHC clinic (described as IM in this study), which revealed very high patient 
satisfaction with care received there (with 62% calling it “best care ever” or “excellent”).  
Authors note that these types of findings highlight the usefulness in learning why patients are 
so satisfied with IHC care, that “results suggest that an IM approach contributes to high 
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levels of patient satisfaction and improved perceptions of physical health [and that] data lend 
support for the movement toward integrative health care currently seen in hospitals and 
private practices across the country” (p. 825-26).  Summaries of these three studies are listed 
in Table 2-6.
Table 2-6.  Literature Review:  Patient Preferences for Integrative Health Care
Author(s) Year Title Findings
Koithan, M., I. R. 
Bell et al. 2007
"Patients' experiences and 
perceptions of a 
consultative model 
integrative medicine 
clinic: a qualitative study"
• Overall satisfaction with IM:
• “expansion of treatment options; lower perceived 
toxicity than conventional therapies, 
• positive experiences of the IM physician as caring and 
taking time to listen
• improved self-care skills and sense of empowerment.”
• “Cancer patients noted positive relationships with their 
conventional MDs more than did non-cancer patients, 
although both groups appreciated the IM physicians' 
communication styles.”
McCaffrey, Pugh 
and O’Connor 2007
“Understanding patient 
preference for integrative 
medical care: results from 
patient focus groups”
Participant beliefs:
• Combination of CAM and conventional medicine is better 
than either alone.
• Health is a combination of physical, emotional, and 
spiritual well-being.
• Nutrition and lifestyles play roles in wellness.
• Pharmaceuticals should be avoided except as last resort
• Participants suffer from health problems not well-treated 
by conventional medicine.
• Want to discuss CAM with doctors and get guidance.
• Want time with providers, be listened to, and have 
opportunities for shared decision-making.
Myklebust, M., E. 
K. Pradhan et al. 2008
"An integrative medicine 
patient care model and 
evaluation of its outcomes: 
the University of Michigan 
experience"
• Improvement to body, mind and spirit, more impact on 
physical than mental health. 
• Great patient satisfaction (62% called it “best care ever” or 
“excellent”).
Patient preferences for IHC from these studies can be summarized by the following two 
quotations from focus group participants that capture their satisfaction with and belief in 
IHC:
I really like that things are integrated and there are all these different options…
[and] all of them are considered as valid options depending on what works for 
you.  I like seeing a doctor who is aware of the bigger picture. Even if she decides 
or recommends a conventional treatment, at least I know they’re aware of 
alternative health thinking… that gives me more confidence in the treatment (p. 
1501).
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For the first time I felt like the various and seemingly disparate symptoms I was 
coming in with actually made sense to my healthcare provider and fit within a 
framework that that person understood, and also within a treatment model that 
that person understood, and then could be used to help make me better—which it 
is, and I am (p. 1503).
 This review of patient IHC preferences highlights the satisfaction that many IHC 
users expressed.  Research on the use of CAM therapies is only half of the equation and 
keeps CAM therapies and conventional medicine distinct and separate.  The other half is 
finding out what patients seek in IHC.  Thus, while the examination of CAM use by 
transplant recipients is valuable, it is equally important to assess their IHC preferences to find 
out how to improve their clinical care and the larger health care system.  
 While the National Health Interview Survey (NHIS) instrument measures the general 
population’s use of CAM therapies and their reasons for use, this review revealed the dearth 
in literature on what patients seek in IHC.   There has been no research to address this study’s 
third research sub-question (Do solid organ transplant recipients seek IHC, and if so, why?), 
including the NHIS instrument.  This study takes the NHIS findings a step beyond CAM use 
to IHC preferences in order to identify patient needs and develop policy recommendations to 
improve patient care.
Conclusion
 This literature review reveals the gap in knowledge about how and why solid organ 
transplant recipients are using CAM therapies and highlights the need to examine these 
topics in depth.   It sheds light on the significance of understanding what patients seek in the 
blended model of care that IHC represents.  It also provides the larger context—trends, 
determinants, predictors, and next steps—into which this study fits.  
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 As stated in chapter one, transplant recipients make up a sizable number of patients in 
the U.S. health care system.  Understanding their use of therapies outside of conventional 
medicine, the reasons for this practice, and their preferences related to the integration of 
CAM and conventional medicine will ultimately help to improve care for this population and 
delivery of health care in general.  This study makes two main contributions:  1) Provides in-
depth understanding on the use of CAM in the U.S. transplant recipient population, and 2) 
Identifies IHC preferences of this sample of high users of the health care system.
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Chapter Three - METHODS
 This study employed a single-stage design that utilized an online survey for primary 
data collection.  Quantitative and qualitative data were collected through an online 
questionnaire incorporating CAM-related questions from the 2007 National Health Interview 
Survey (NHIS) and new IHC-related questions.  The questionnaire was distributed to United 
States solid organ transplant recipients using email, listserv, online posting, transplant center, 
and organ procurement organization requests for participation.  I sought to assess CAM use 
by transplant recipients, their reasons for it, and their preferences related to IHC.
Conceptual Framework
 The CAM Healthcare Model (so named by its creators) is based on Andersen’s 
Behavioral Model of Health Service Use, which has been “used extensively over the past 
three decades to guide research examining factors that predict utilization of, and access to, 
conventional health services” (Fouladbakhsh & Stommel, 2007).  This new model expands 
upon the Behavioral Model to also include the examination of self-directed CAM practice 
and use of CAM products and resources.  Examples include:  1) provider services (e.g., 
acupuncture, naturopathy, massage, chiropractic), 2) self-directed products and resources 
(e.g., nutritional supplements, herbs, essential oils), and 3) self-directed practice (e.g., yoga, 
deep breathing, meditation).
 The CAM Healthcare Model predicts that Predisposing Factors (i.e., individual, 
social, and community level demographics), Enabling Factors (i.e., resources, access, 
availability, and geography), and Need for Care Factors (i.e., evaluated and perceived health 
needs) correlate with health service use and outcomes of care.  Fouladbakhsh and Stommel’s 
model is depicted in Figure 3-1.
Hypotheses
 This study utilized the CAM Healthcare Model to determine whether it correlates 
with solid organ transplant recipient CAM use.  The following hypotheses were tested:
H1 = Solid organ transplant recipients will use CAM at higher rates than the general 
population.
Figure 3-1.  CAM Healthcare Model (Fouladbakhsh & Stommel, 2007)
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H2 = Select predisposing, enabling, and need for care factors will predict CAM use for 
solid organ transplant recipients.
H3 = Solid organ transplant recipients will want someone who knows about both 
conventional medicine and non-conventional practice to serve to integrate their 
care. 
For H2, the predisposing, enabling, and need for care factors include:  gender, age, and 
education (predisposing), income and geographic location (enabling), and perceived health 
status (need for care).
Data Source
 Ideally, a list of all solid organ transplant recipients who live in the United States 
would have been cross-referenced with a database of all transplant recipient deaths to 
calculate the total living transplant recipient population.  Because data do not exist to 
determine this number, this study used a convenience sample as described next.
 Exclusion criteria:  Solid organ transplant recipients who self-identified that their 
transplanted organ(s) failed and/or they were transplant candidates on the Organ Procurement 
and Transplantation Network (OPTN)/United Network for Organ Sharing (UNOS) waiting 
list at the time of the survey were excluded.  People who self-identified as transplant 
recipients but not of solid organs (e.g., bone marrow, tissue, cornea) were excluded.  People 
whose permanent residences were outside of the United States were excluded.  Subjects 
under 18 years were excluded due to the need for guardian consent for participation.  Parents 
and guardians were excluded from completing the survey for their underage recipient 
children.
 Subjects had to be able to read and understand English (or have someone interpret for 
them) and complete the online survey on a computer with internet access.  Those who 
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completed the questionnaire were asked to provide the following demographic information:  
gender, age, health status, level of education, marital status, race, household income, 
insurance coverage description, and zip code.  Subjects were also asked to identify:  type(s) 
of transplanted organ(s), date of last transplant surgery, type of donor (living or deceased) in 
most recent recent transplant surgery, and whether they knew their living donor. 
 The size of the sample population was determined by the number of people who 
responded to the request and completed the survey during the specified one-month data 
collection period.  People who did not have access to a computer and the internet or were 
otherwise unable to complete the survey during the data collection period were unable to 
participate.  Subjects were asked to complete the survey only one time, and the online survey 
program marked whether multiple surveys were completed at the same IP address.   
Instrument
 The survey instrument [Appendix B] was based on the National Health Interview 
Survey, which was administered by the Centers for Disease Control and Prevention’s (CDC) 
National Center for Health Statistics (NCHS) to the general U.S. population in 2002 and 
2007.  Only questions from the Sample Adult CAM survey of the 2007 NHIS were used.  
(For consistency, questions from the Sample Child questionnaire were not included.)  Written 
permission to use this survey was received from the National Center for Complementary and 
Alternative Medicine on December 31, 2009.
 This instrument was selected because of:  the validity and reliability of research 
questions, its past use with very large sample sizes (n=31,044 in 2002; n=23,393 in 2007), 
the ability to compare results with two different large-scale studies’ finding [NHIS and 
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Eisenberg] (Tindle, Davis, Phillips, & Eisenberg, 2005), and the promotion of consistent 
definitions of CAM therapies.  Four additional questions on patient preferences for IHC were 
created and included in the questionnaire used for this study: 
1. Does someone (inc. yourself) currently integrate/facilitate the combining of your 
conventional and non-conventional care?  [Yes/No]
2. [If Yes] Please rank each person who helps facilitate your integrative care in order of her/
his involvement. You need only rank as many as apply, and if no one helps you then please 
mark "No one".
- Medical doctor 
- Nurse
- Dietician/Nutritionist
- Alternative provider(e.g., chiropractor, naturopath)
- I do it myself 
- No One
- Other
- If you ranked "Other", who is "Other"?
3. Would you want someone who knows about both conventional medicine and non-
conventional practice to serve as an integrator for your care?  [Yes/No]
4. [If Yes] Would you want this integrator to be any of the following (please rank up to top 
five, only as many as apply):
- Psychologist/Social worker 
- Pharmacist
- Dietician/Nutritionist
- Doctor of Osteopathy (D.O.)
- Medical doctor (MD, including specialists and psychiatrists)
- Physician Assistant (PA), Nurse (RN), or Nurse practitioner (NP)
- Dentist
- Alternative provider like an acupuncturist or chiropractor)
- A trained integrator who has knowledge of conventional and complementary therapies
- Me
- Someone else
- If you ranked "Someone else", who is "Someone else"?
  These above questions were tested by a small group of anonymous volunteers 
ahead of time to ensure their intent and meaning were clear and understandable.   This group 
was comprised of 10 solid organ transplant recipients who live in the United States.  They 
responded to an email request sent by the National Kidney Foundation to a list of their 
transplant recipients who are known as “reliable volunteers”.  The identities of those who 
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received the email request and those who pretested the survey were unknown to the 
researcher.
 The pre-test respondents reported the following:  100% (n=10) found the length of 
time it took to complete the survey “manageable”,  and 44% of the nine (9) people who 
responded to the query stated that the questions were clearly-worded.   As a result of 
feedback from the five (5) respondents who did not think all the questions were clear, a more 
concise definition of integrative health care was provided, the questions were re-ordered,  
and the option to select “never used any CAM therapies” was added.  
 The 27-question survey was divided into three (3) topical sections:  1) Demographic 
Information, 2) CAM Use, and 3) IHC Preferences.  It was designed to assess what, if any, 
CAM therapies respondents use (including how often, cost, communication with 
conventional medicine provider), why they use these therapies (i.e., for what health reasons, 
perceived benefits/side effects), and what they seek in integrative health care (e.g., type of 
integrator, goals of care).  Subjects provided answers to questions by marking yes/no/don’t 
know, ranking choices, selecting from multiple choices, and completing open-ended text 
boxes (for qualitative responses).
  The questionnaire was administered as an online survey using the web-based service, 
QuestionPro.com.  The survey included an initial letter of consent after which research 
subjects had to manually opt in to participate by checking a box and clicking on “enter”, a 
section on demographic information, several pages of questions related to CAM and IHC, 
and a last page for open-ended comments.  The web-based service marked whether 
respondents completed the survey more than one time.  It also collected and tabulated the raw 
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data, which were exported into Excel spreadsheets for statistical analyses in the software 
program, PASW (formerly known as SPSS) Statistics 18.
Procedure
 Survey data were collected during a specified one-month period that started on 
August 20, 2010 and concluded on September 19, 2010.  An email request for survey 
participants was disseminated through known transplant community listservs, group emails, 
and websites.  Transplant center administrators and regional organ procurement organization 
heads were also asked to forward the request to local transplant groups.  In order to reduce 
selection bias, the initial email request for participation [Appendix C] did not specify the 
topic of research (i.e., CAM) and instead stated “research on transplant recipients’ health care 
experiences”.  A recruitment flyer for posting [Appendix C] was included in the request, as 
was an online link from where it could be downloaded.
 The initial request for participants was sent to contacts to disseminate it to the 
following listservs and mailing groups:
• National Kidney Foundation (NKF) “People Like Us” listserv (1,307 members)
• NKF LiveDonor listserv (291 members)
• NKF transAction listserv (2,310 members)
• NKF Twitter account (78 followers)
• NKF [U.S. Transplant Games] Team Manager listserv (~60 members)
• Transplant Recipient International Organization’s e-newsletter list (400+ subscribers)
• United Network for Organ Sharing (UNOS) Patient Affairs Committee current and 
past recipient members (23 recipients)
• UNOS Transplant Administrators listserv (387 members)
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Representatives of the following organizations/companies were asked to forward the request 
to clinical coordinators at the 273 transplant centers across the country:
• Astellas Pharma U.S. Inc.
• Roche USA
• UNOS
• Organ procurement organizations (56 total)
The initial request was posted on the following websites, social networking pages, and online 
communities by site administrators or members:
• NKF “People Like Us” Facebook page (1,088 friends)
• NKF Transplant Games Facebook page (2,353 friends)
• Donate Life Linkedin page (981 members)
• Transplant Living Facebook page (4,100 friends)
• UNOS Facebook page (5,720 friends)
• Transplant Cafe page (2,701 members)
• IHateDialysis.com message board (4,867 members)
 
A follow-up email request [Appendix C] was sent 21 days after the start of the survey via the 
same channels—except for the organ procurement organization heads because of several 
responses that many did not have ample direct contact with transplant recipients—to remind 
participants to complete the questionnaire during the designated one-month time period.
 The survey program collected the raw data, which were exported into Excel 
spreadsheets and downloaded every few days.  These reports were backed up on a password-
protected hard drive and remote server.  Numerous survey participants and potential 
participants contacted the researcher and her dissertation committee chair for clarification on 
the correct online survey link (because some recruitment material included an incorrect link), 
to confirm the legitimacy of this research, and just to share their personal health experiences 
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and transplant stories.  For the third reason, respondents were asked to either complete the 
survey and include their personal experiences in the final open-ended comment box or to 
send the researcher an email message for the qualitative data to be included.  (Only one 
person emailed the researcher.) 
Statistical Analysis
 The survey program tallied the responses and generated online reports based on the 
collected data.  The raw data were exported into Excel spreadsheets first to manually collapse 
the multiple rows of entries listed for each respondent into a single row.  Every tenth entry 
was double-checked for accuracy, and the full dataset was then imported into the statistical 
software program, PASW (formerly known as SPSS) Statistics 18.  Before analyzing, the 
data were checked for missing response patterns, skip patterns, and out-of-range values.  
Where appropriate, values were regrouped and recoded for easier interpretation and 
comparison.  Two-tailed statistical tests at the .05 level were used to compare estimates by a 
biostatistician who assisted with this process.  A simple multiple regression was performed to 
test for predictive factors for CAM use.
Data Limitations
 Data limitations include the fact that responses were limited to those who were 
already in some sort of existing transplant community or network (which enabled them to 
receive the request for participation), were interested in or open to completing questionnaires, 
read and understand English (or had access to an interpreter), have access to a computer and 
the internet, and were computer- and internet-literate enough to participate.  Survey 
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responses were also self-reported by participants, and their answers represented only single 
points in time that were based on their own recollections.
Confidentiality, Risks, and Benefits related to Subjects
 Risks to study subjects were minimal.  All questionnaires were completed 
anonymously, and contact information for the researcher and her committee chair was 
provided to subjects for questions or clarification.  The data were stored on the researcher’s 
password-protected hard drive, remote back-up server, and online survey site.
 There were minimal benefits to the subjects who participated in the online 
questionnaire.  Potential benefits of this study for society include:  1) increasing knowledge 
related to CAM use by solid organ transplant recipients, 2) identifying IHC preferences of 
solid organ transplant recipients, and 3) developing health policy recommendations related to 
intensive users of the health care system.
 Because this research involved surveying human subjects, initial approval from the 
University of North Carolina (UNC) Institutional Review Board was sought to ensure their 
protection and obtained on March 1, 2010.  After the pre-test group tested survey instrument 
questions for clarity and understanding, final IRB approval was received on July 30, 2010, 
through February 28, 2011.  No research was initiated before this approval was granted.  A 
one-year extension through January 11, 2012 was granted on January 12, 2011.
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Chapter Four - RESULTS
 In this chapter, overall study findings are first compared with those presented in the 
2007 NHIS CAM report, “Complementary and Alternative Medicine Use Among Adults and 
Children: United States, 2007” (Barnes PM, 2008).  This comparison of results includes:  
sample populations,  prevalence of CAM use, most commonly-used CAM therapies, reasons 
for CAM use, and characteristics of CAM users.  A presentation of additional key findings 
related to IHC and a discussion of how the results relate to the CAM Healthcare Model 
follow.
Study Population
 A total of 1,108 individual people started the online questionnaire (i.e., checked off 
“Enter” on the initial consent page).  The overall response rate of this group was 71.1%, with 
788 respondents completing the survey and providing usable data:  517 subjects completed 
the questionnaire, and 271 answered all the questions but did not click on the final 
“Continue” button to reach the “Thank you” page and formally conclude the survey.4   It took 
an average of 18 minutes for participants to complete the survey.  The 788 respondents came 
from 47 states and the District of Columbia; Alaska, Idaho, and Nebraska were not 
represented. 
4 Although about half of the 400,000 people who received solid organ transplants are estimated to be alive 
(please see Footnote #2 on page 5) and this sample size only represents a small fraction of the total recipient 
population, it is the largest study of its kind.  In comparison, Crone and Wise (1997) studied 323 recipients who 
received care at the same transplant center, and Hess et al. (2008) examined data from 356 recipient patients at 
two Swiss clinics.
 Three hundred nineteen (319) participants dropped out after starting the survey, and 
this number included 64 surveys that were automatically terminated due to branching.  
Specifically, their responses—under the age of 18 years, not a solid organ transplant 
recipient, currently on the transplant waiting list due to a failed graft—excluded them from 
participating.  The data collected from one (1) person who completed the survey were 
excluded because the place of residence was not in the United States.  (The respondent 
revealed having used an outdated U.S. zip code only to be able to continue with the survey.) 
 The demographics of the study’s sample (n=788) are listed in Table 4-1.  Certain 
NHIS sample figures are listed in italics because they do not match study categories exactly.  
Compared with the NHIS population [n=23,393], which was “a nationally representative 
sample of the civilian noninstitutionalized household population of the United 
States” (Barnes PM, 2008), this transplant recipient sample includes:
• a smaller percentage of people 18 to 44 years old and a larger percentage of people in 
the 45-64 years of age range, 
• a greater proportion of people who earned a college degree or higher,
• a much smaller percentage of people lacking health insurance,
• similar household income breakdowns,
• a greater proportion of people either married or living with a partner,
• a greater segment of people living in the Northeast region of the United States, and
• a greater proportion of people self-assessing their health status as Mostly Good to 
Excellent.
Differences between the two populations are highlighted in Table 4-2.
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Table 4-1.  Demographic characteristics of study sample and 2007 NHIS population
Study sample
(n=788)
Study sample 
(% of whole 
population)
2007 NHIS 
sample 
(n=23,393)
 Sex Male 377 47.8% 48.3%
Female 411 52.2% 51.7%
 Age 18-44 206 26.1% 49.7%
 (in years) 45-64 437 55.5% 34.1%
65-74 126 16.0% 8.6%
75 and older 19 2.4% 7.6%
 Race Caucasian 666 84.5% 81.0%
Hispanic 34 4.3% 13.4%
African-American 41 5.2% 11.8%
Native American or Alaska Native 5 0.6% 0.1%
Pacific Islander 2 0.2% 0.1%
Asian 27 3.4% 4.7%
Other 13 1.6% 1.3%
 Education* Less than high school 7 0.9% 13.3%
Some high school 10 1.3%
High school degree/GED 71 9.0% 24.8%
Some college 202 25.6% 22.5%
College degree 292 37.1%
25.5%
Graduate degree 206 26.1%
 Income# Less than $10,000 37 4.7%
31.2%
$10,000 to under $50,000 221 28.0%
$50,000 to under $70,000 159 20.2% 13.6%
$70,000 to under $100,000 161 20.4% 16.9%
10.8%
$100,000 or more 210 26.6% 17.0%
 Health Insurance+ Insured 769 97.6%
Uninsured 19 2.4% 16.7%
 Marital status Single (Never married) 121 15.4% 20.4%
Married 535 67.9% 55.6%
Living with partner (Cohabitating) 86 10.9% 6.6%
Divorced (Divorced or separated) 28 3.6% 10.8%
Widowed 18 2.3% 6.3%
 Region Northeast 189 24.0% 17.1%
Midwest 170 21.6% 24.1%
South 277 35.2% 36.7%
West 152 19.3% 22.1%
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Table 4-1.  Demographic characteristics of study sample and 2007 NHIS population
Study sample
(n=788)
Study sample 
(% of whole 
population)
2007 NHIS 
sample 
(n=23,393)
 Health status^ Excellent 141 17.9%
60.2%Very Good 259 32.9%
Mostly Good 189 24.0%
Good 83 10.5% 25.8%
Fair 63 8.0%
13.2%Challenging 46 5.8%
Poor 5 0.6%
* Education categories did not completely match for two populations.
# NHIS household income categories were:  <$35K, $35,000-$49,999, $50,000-$74,999, $75,000-$99,999, and 
$100,00 and more.
+ The only comparable health insurance category was “uninsured”.  In this survey, respondents did not have to list 
their type of insurance coverage as NHIS participants did.
^ NHIS health status fields were:  Excellent or Very Good, Good, and Fair or Poor.
Table 4-2.  Selected demographics of study sample and 2007 NHIS sample populations
Study sample 2007 NHIS sample
Age: 18-44 years 26.1% 49.7%
Age:  45-64 years 55.5% 34.1%
Education level:  Some college, 
college degree, or graduate 
degree
88.8% 48.0%
Household income:  $50,000 or 
more 67.2% 58.3%
Household income:  $100,000 or 
more 26.6% 17.0%
Medical insurance:  No coverage 2.4% 16.7%
Marital status:  Married or 
Living with Partner 78.8% 62.2%
Region:  Northeast 24.0% 17.1%
Health status:  Mostly Good to 
Excellent 74.8% 60.2%
 The differences in age demographics between the two samples can be partially 
attributed to the fact that solid organ transplant recipient populations generally skew older 
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because older people live with more comorbidities than younger people.  Between 2005 and 
2009, 38.1% of all solid organ transplant recipients were ages 18-49 years while more than 
half (54.9%) were 50 years or older ("Organ Procurement and Transplantation Network 
online database," 2010).   This breakdown holds true in the sample population.  Anecdotal 
information suggests that younger transplant recipients might not be fully represented in this 
research sample because they might not be interested in participating in a survey, have 
moved on to live “normal lives” and are therefore not members of transplant communities/
networks, or have had transplant surgeries more recently and be dealing with the issues 
related to recovery.5  
 The reasons for the disparity in educational levels between the two populations may 
be related to the older age of the sample group because there could be proportionately fewer 
younger people who might have not yet finished college.  The higher educational level of the 
sample population could also be due to self-selection:  those who are members of online 
transplant networks, have access to computers and the internet, and are interested in 
completing an 18-minute survey might be those who are more educated.    
 Along these same lines, education is associated (to a degree) with income level (Card, 
1999), and this may help explain the higher household incomes seen in the sample 
population.  The exceptionally low lack of insurance coverage might be related to higher 
incomes (and subsequent work-related insurance coverage), but it could also be the result of 
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5 “The “best of reasons”...would be that the transplant was very successful, they feel good and have plunged 
back into life fully and that transplant is just a piece of their life rather than a “definition” of who they are.  
However, research data shows that young men in particular are non-adherent with meds and post transplant 
requirements—that would point to a somewhat usual rebellious nature of male teens/young men that translates 
into a “denial, inability to accept their chronic condition” and hence a “turning away” and avoidance of 
anything that could be helpful to them such as support/education/getting involved in the cause.” (C. Paykin, 
personal communication, March 10, 2011).
the Medicare coverage that kidney transplant recipients receive for 36 months post-transplant 
(and that also covers the transplant surgery).
 The data collected on type of health insurance coverage were not reliable enough to 
assess who was covered by what kind of insurance because some respondents were unclear 
about how to answer and populated all choices.  The survey question was:  “My insurance 
coverage is (select as many as apply): Private [Y/N], Public [Y/N], and [open-ended text 
box].”  For example, many respondents listed a third party payer’s name under “Private” and 
then listed Medicare under “Public”.  It was unclear whether the former was really the private 
payer-managed Medicare plan or a second private plan.  Data from the 2007 NHIS are more 
reliable because interviewers asked respondents in person to identify type(s) of insurance 
coverage from a list of providers.
 There are no obvious reasons why the subjects in this study population are in married 
or committed relationships and self-rate their health status highly.   Perhaps transplant 
recipients in stable relationships have more time to complete surveys or are interested in 
helping others.  The large percentage (78.8%) of respondents who are either married or living 
with a partner may, however, relate to the higher levels of household income in this 
population.  However, without the ability to compare single-person residence status and 
household income level in the 2007 NHIS population, this possible relationship cannot be 
ascertained.  
 The high percentage (74.8%) of recipients who self-rated their health status as Mostly 
Good to Excellent—with over half (50.8%) describing their health as Very Good  or Excellent
—was an unexpected finding.  This is a population with members who have experienced 
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organ failure, have undergone at least one significant surgery, and are encouraged to follow a 
post-transplant protocol.  Nearly all solid organ transplant recipients take daily 
immunosuppressive medication for the grafted organ(s), and these immunosuppresives often 
result in side effects.  (The exceptions are those who received grafts from their identical 
twins or who have fared well without immunosuppression.)  Transplant recipients often also 
deal with the effects of living with the comorbidities that led to organ failure, as well as other 
conditions that can arise after transplantation and their related treatments.6  One possible 
explanation could be that because recipients feel so much better and are so happy to be alive 
after the transplant, the high Mostly Good to Excellent health status rate could be artificially 
inflated.  Although this was a self-selecting convenience sample that opted in to participate in 
the survey, this finding is very interesting and warrants further research. 
 Finally, it is unknown why there are disproportionately more respondents who live in 
the Northeast Region7 in the study population.  One possibility is that the response rate may 
be related to geographic proximity of the person or organization forwarding the request for 
study participants.  One heart recipient, who is very active with several transplant 
communities in the Pennsylvania-New Jersey-New York area and who is a personal friend of 
this researcher, may have made a personal plea to those in these same networks to participate 
in the survey.  This might have resulted in higher participation from this geographic area.  In 
addition, the National Kidney Foundation posted the call for participants on its social media 
sites and sent it out through several of its listservs.  It is possible that those who are 
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6 Hypertension prevalence rates for kidney transplant recipients range from 60-80%, and estimates for non-renal 
transplant recipients is up to 90% (Martínez-Castelao, 1998).
7 The Northeast Region is comprised of the following states:  Maine, Vermont, New Hampshire, Massachusetts, 
Connecticut, Rhode Island, New York, New Jersey, and Pennsylvania.  Please see Appendix A for the 
definitions used in the 2007 NHIS instrument.
geographically closer to the Foundation—located in New York City—are more active with it 
and willing to participate in activities it publicizes.  Finally, the larger percentage of 
respondents from the Northeast region could merely be representative of the area being more 
highly populated than others in the country.  Regardless of the reason, it is worth noting the 
differences between the study population and that of the 2007 NHIS’, as shown in Table 4-3.
Table 4-3.  Residence of survey respondents in study and NHIS samples
Region Study NHIS
Northeast 24.0% 17.1%
Midwest 21.6% 24.1%
South 35.2% 36.7%
West 19.3% 22.1%
 Finally, the transplant-related demographics of this population are shown in Table 
4-4.  The vast majority (81.3%) of respondents only had one transplant surgery, and more 
than half (54.5%) received a kidney during their first surgery.  There are no comparable data 
to compare “number of transplant surgeries” and “time since last transplant surgery” with any 
national population, but the breakdown of transplanted organs is compared with the national 
average of types of transplanted organs in the United States between 2005-2009 ("Organ 
Procurement and Transplantation Network online database," 2010).  
 It should also be noted [Table 4-4] that the study population includes a high 
percentage of respondents with longer-lasting graft survival rates:  over half (63.5%) of 
participants were 5+ years out from their last transplant surgery, with 37.3% of the total study 
population reporting a graft over 10 years old.  Because there are no comparable data, it is 
merely an observation that this is an “experienced” group of transplant recipients who 
provided input on their use of and preferences for health care.
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Table 4-4.  Transplant-related demographics of study population
Number of subjects Study % National %
Number of Transplant Surgeries N=788
One 641 81.3% NA
Two 129 16.4% NA
Three 13 1.6% NA
Four 3 0.4% NA
Five 1 0.1% NA
Six 1 0.1% NA
Type of First Transplant N=788
National average 
(2005-09)*
Kidney 432 54.8% 61.1%
Kidney-Pancreas 32 4.1% 3.2%
Heart 108 13.7% 8.0%
Heart-Lung 6 0.8% 0.1%
Liver 169 21.4% 19.1%
Pancreas 11 1.4% 1.7%
Double Lung+ 29 3.7%
5.4%Single Lung+ 12 1.5%
Intestine 12 1.5% 0.7%
Time Since Last Transplant Surgery N=786
Less than 1 year 43 5.5% NA
1 to <2 years 121 15.4% NA
3 to <5 years 123 15.6% NA
5 to <10 years 206 26.2% NA
10+ years 293 37.3% NA
* Organ Procurement and Transplantation Network online database (2010).
+ Single versus double lung transplants are not distinguished.
Prevalence of CAM Use
 This study found that the use of complementary and alternative medicine is higher in 
the sample population than the general population, even with the growth documented in the 
2002 and 2007 NHIS reports.  Over half (56.9%) of the transplant recipients surveyed 
reported using at least one form of CAM therapy in the twelve months prior to taking the 
survey.  As Figure 4-1 shows, this compares with 36.0% of the general population in 2002, 
and 38.3% in 2007.  In addition, 64% of the study population responded that they had used at  
least one CAM therapy in their lifetime.
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Most Commonly-used CAM Therapies
 Modeled after the NHIS study, the 22 different CAM therapies were organized into 
five (5) distinct categories:  “Alternative medical systems”, “Biologically-based therapies”, 
“Manipulative and body-based therapies”, “Mind-body therapies”, and “Energy healing/
Reiki”.   Of these, 34.6% of the transplant recipients in the study used at least one 
biologically-based therapy in the last year, 25% of them utilized at least one manipulative or 
body-based therapy during this same time period, and 16.8% employed a mind-body therapy.  
Less than one-tenth of respondents (6.7%) used an alternative medical system or energy 
healing therapy (1.0%) in the previous 12 months. 
15%
30%
45%
60%
56.9%
38.3% 36.0%
Study Sample 2007 NHIS Sample 2002 NHIS Sample
Percentage of respondents who reported CAM use in the last 12 months
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Figure 4-1.  Comparison of CAM Users
 The study’s sample size was too small to analyze use of individual therapies, but 
nonvitamin, nonmineral, natural products8 (n= 261) and massage (n=148) were the most 
frequently-used CAM therapies.  This population’s use of CAM therapies is compared with 
that of the NHIS general population in Table 4-5.  The number of users of each therapy 
within a category do not equal the total number of users in each category because users were 
able to mark multiple therapies used in the previous 12 months.  If more than one therapy 
within a category was marked, the response was counted as only one entry.
Table 4-5.  Complementary and alternative medicine therapies used by participants in two studies
Number of users Study % National %
EVER used 504 64.0%
USED in last year 448 56.9% 38.3%
Alternative medical systems 53 6.7% 3.4%
Acupuncture 28 3.6% 1.4%
Ayurveda 3 0.4% 0.1%
Homeopathic treatment 14 1.8% 1.8%
Naturopathy 8 1.0% 0.3%
Traditional healer 16 2.0% 0.4%
Biologically based therapies 173 34.6% 19.9%
Chelation therapy 1 0.1% 0.0%
Nonvitamin, nonmineral, natural products* 261 33.1% 17.7%
Diet-based therapies 55 7.0% 3.6%
Manipulative and body based therapies 197 25.0% 15.2%
Chiropractic care 74 9.4% 8.6 w/osteo
Osteopathic manipulation 9 1.1% 8.6 w/chiro
Massage 148 18.8% 8.3%
Movement therapies 19 2.4% 1.5%
Mind-body therapies 132 16.8% 19.2%
Biofeedback 2 0.3% 0.2%
Meditation 51 6.5% 9.4%
Guided imagery 21 2.7% 2.2%
Progressive relaxation 18 2.3% 2.9%
52
8 Orally-ingested products that are not vitamins or minerals such as herbs, herbal medicines, and dietary 
supplements.  Please see Appendix A for a full description from the NHIS instrument.
Table 4-5.  Complementary and alternative medicine therapies used by participants in two studies
Number of users Study % National %
Deep breathing exercises 49 6.2% 12.7%
Hypnosis 6 0.8% 0.2%
Yoga 63 8.0% 6.1%
Tai chi 38 4.8% 1.0%
Qi Gong 4 0.5% 0.3%
Energy healing/Reiki 8 1.0% 0.5%
* Nonvitamin, nonmineral, natural products data are not comparable between the two populations.
 One interesting, unexplained observation is the higher than expected use of ingestible 
CAM therapies (oral or IV supplements and treatments in the “Biologically-based” and 
“Alternative medical systems” CAM categories) that could potentially interfere with 
transplant medications.  I initially thought that transplant recipients would opt for 
noninvasive CAM therapies like guided imagery, Reiki, deep breathing, and movement 
therapies to avoid potential adverse effects with immunosuppressive medications.  However, 
“Mind-body therapies” was the one CAM category that subjects used at a lower rate than the 
national population.
Reasons for CAM Use
 The second research sub-question in this study was “Why are solid organ transplant 
recipients using CAM?”  The main reason for CAM use expressed by transplant recipient 
participants was back pain or problem, which was also the top reason cited by 2007 NHIS 
respondents.  Other musculoskeletal conditions—neck pain or problem and joint pain or 
stiffness— ranked high in both groups.  Whereas these were the top three reasons for CAM 
use by the national sample, the transplant population listed don’t know and anxiety as the 
second and third problems.  Tables 4-6 and 4-7 list the main reasons for CAM use in both 
populations.  
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Table 4-6.  Main reasons for CAM use in transplant recipient population
Reason for CAM Use
Number of 
respondents
Percentage of all CAM 
Users
Percentage of all 
conditions
Back pain or problem 71 9.0% 25.5%
Don’t Know 34 4.3% 12.2%
Anxiety 18 2.3% 6.5%
Neck pain or problem 16 2.0% 5.8%
Joint pain or stiffness 12 1.5% 4.3%
Weight 12 1.5% 4.3%
Arthritis 10 1.3% 3.6%
Table 4-7.  Main reasons for CAM use in 2007 NHIS population
Reason for CAM Use Percentage of all CAM Users (2007)
Back pain or problem 17.1%
Neck pain or problem 5.9%
Joint pain or stiffness 5.2%
Arthritis 3.5%
Other 3.3%
Anxiety 2.8%
Cholesterol 2.1%
 In the 2007 NHIS study, the top four (31.7%) reasons for CAM use are 
musculoskeletal problems and account for nearly one-third of the total.  In contrast, the 
transplant study population cited a musculoskeletal problem (back pain) first, don’t know 
next (despite the option to select “Other”), and a mental health/emotional concern (anxiety) 
third.  These responses lead to questions of whether subjects just want to feel better, deal with 
abstract or concrete side effects not listed in survey choices, experience unaddressed or 
“under-addressed” anxiety of living with a chronic condition, or something other.  The 
inclusion of weight in the list of most common reasons for CAM use also raises questions 
about whether weight (gain) due to immunosuppressives or recovery weight or inability to 
exercise (sun sensitivity, other) is addressed adequately in post-transplant care.
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Characteristics of CAM Users
 As with the 2007 NHIS and other samples, prevalence of CAM use was higher with 
women, younger adults,9 people with higher levels of education, and those living in the 
Western region of the United States.  There were no associations with race, household 
income, health insurance coverage, marital status, or self-rated health status.  
 Table 4-8 compares the demographics of CAM users in the study and NHIS 
populations.  The figures in the two columns on the right represent the percentage of people 
in each demographic category who are CAM users (e.g., the 249 women who used CAM in 
the past year make up 60.6% of all women in the study).   As shown in Table 4-8, statistical 
tests revealed that CAM usage was positively correlated with female gender and higher level 
of education, with p values of less than .05.  This presentation format replicates that of the 
2007 NHIS report (Barnes PM, 2008).  Table 4-9 presents a complementary way to view the 
data and compares CAM users and non-users in this study.
Table 4-8.  Demographics of CAM users: 2010 study and 2007 NHIS sample populations
Study
Study
(% of field)
NHIS 
(% of field)
TOTAL
Sex
Age
448 56.9% 28.3%
p=.027, r=.079
Male 199 52.8% 33.5%
Female 249 60.6% 42.8%
p=.677, r=.015
18-29 26 52.0% 36.3%
30-39 46 57.5% 39.6%
40-49 93 58.1% 40.1%
50-59 148 59.2% 44.1%
60-69 108 55.1% 41.0%
70-84 27 52.9% 32.1%
85 and over 0 0.0% 24.2%
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9 Whereas the 2007 CAM study defined “younger” as ages 30-69 years of age, the overall NHIS sub-population 
is 30-59 years.
Table 4-8.  Demographics of CAM users: 2010 study and 2007 NHIS sample populations
Study
Study
(% of field)
NHIS 
(% of field)
Age
Race
Education*
Income#
Health Insurance+
Marital status
Region
p=.286, r=-.038
30-69 395 88.2%
not 30-69 53 11.8%
p=.447, r=.027
Caucasian 383 57.5% 43.1%
Latino 17 50.0% 23.7%
African-American 20 48.8% 25.5%
Native American or Alaska Native 3 60.0% 50.3%
Pacific Islander 0 0.0% 43.2%
Asian 15 43.2% 39.9%
Other 9 69.2%
P=.02,  r=-.083
Less than high school 1 14.3% 20.8%
Some high school 3 30.0%
High school degree/GED 32 45.0% 31.0%
Some college 114 56.4% 45.0%
College degree 176 60.2% 49.6%
Graduate degree 122 59.2% 55.4%
p=.717, r=.013
Less than $10,000 17 45.9% NA
$10,000 to under $50,000 131 59.3% NA
$50,000 to under $70,000 88 55.3% NA
$70,000 to under $100,000 101 62.7% NA
$100,000 or more 111 52.9% NA
Insured 437 56.8%
Uninsured 11 57.9%
31.5 % (<65) 
11.1% (65+)
p=.133, r=-.054
Single (Never married) 63 52.1% 36.0%
Married 304 56.8% 37.6%
Living with partner (Cohabitating) 18 64.3% 38.1%
Divorced (Divorced or separated) 52 48.8% 38.5%
Widowed 11 61.1% 26.1%
p=.980, r=.001
Married 304 56.8%
Not married 144 56.9%
p=.414, r=1.029
Northeast 110 58.2% 38.0%
Midwest 93 54.7% 41.4%
South 146 52.7% 32.5%
West 99 65.1% 44.6%
56
Table 4-8.  Demographics of CAM users: 2010 study and 2007 NHIS sample populations
Study
Study
(% of field)
NHIS 
(% of field)
Health status^
Number of Transplant Surgeries
Type of First Transplant
Time Since Last Transplant Surgery
* Education categories did not completely match for two populations.
# NHIS household income categories:  <$35K, $35K-$49,999, $50K-$74,999, $75K-$99,999, and $100K and more.
+The only comparable health insurance category was “uninsured”.  In this survey, respondents did not have to list
 their type of insurance coverage as NHIS participants did.
^ NHIS health status fields:  Excellent or Very Good, Good, and Fair or Poor.
p=.179, r=-.048
Excellent 77 54.6% NA
Very Good 140 54.0% NA
Mostly Good 115 60.8% NA
Good 43 51.8% NA
Fair 39 61.9% NA
Challenging 28 60.9% NA
Poor 4 80.0% NA
One 364 56.8% NA
Two 68 52.7% NA
Three 12 92.3% NA
Four 2 66.7% NA
Five 1 100.0% NA
Six 1 100.0% NA
Kidney 243 56.3% NA
Kidney-Pancreas 15 46.9% NA
Heart 60 55.6% NA
Heart-Lung 5 83.3% NA
Liver 97 57.4% NA
Pancreas 5 45.5% NA
Double Lung 20 69.0% NA
Single Lung 8 66.7% NA
Intestine 6 50.0% NA
Less than 1 year 26 60.5% NA
1 to <2 years 69 57.0% NA
3 to <5 years 72 58.5% NA
5 to <10 years 113 54.9% NA
10+ years 167 57.0% NA
57
Table 4-9.  Comparison of CAM users and non-users in study
Users % of total Non-users % of total
TOTAL
Sex
Age
Race
Education
Income
Health Insurance
448 56.9% 340 43.1%
Male 199 52.8% 178 47.2%
Female 249 60.6% 162 39.4%
18-29 26 52.0% 24 48.0%
30-39 46 57.5% 34 42.5%
40-49 93 58.1% 67 41.9%
50-59 148 59.2% 102 40.8%
60-69 108 55.1% 88 44.9%
70-84 27 52.9% 24 47.1%
85 and over 0 0.0% 1 100.0%
30-69 395 88.2% 291 42.4%
not 30-69 53 11.8% 49 48.0%
Caucasian 383 57.5% 283 42.5%
Latino 17 50.0% 17 50.0%
African-American 20 48.8% 21 51.2%
Native American or Alaska Native 3 60.0% 2 40.0%
Pacific Islander 0 0.0% 2 100.0%
Asian 15 43.2% 11 29.7%
Other 9 69.2% 4 30.8%
Less than high school 1 14.3% 6 85.7%
Some high school 3 30.0% 7 70.0%
High school degree/GED 32 45.0% 39 54.9%
Some college 114 56.4% 88 43.6%
College degree 176 60.2% 116 39.7%
Graduate degree 122 59.2% 84 40.8%
Less than $10,000 17 45.9% 20 54.1%
$10,000 to under $50,000 131 59.3% 90 40.7%
$50,000 to under $70,000 88 55.3% 71 44.7%
$70,000 to under $100,000 101 62.7% 60 37.3%
$100,000 or more 111 52.9% 99 47.1%
Insured 437 56.8% 332 43.2%
Uninsured 11 57.9% 8 44.4%
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Table 4-9.  Comparison of CAM users and non-users in study
Users % of total Non-users % of total
Marital status
Region
Health status
Number of Transplant Surgeries
Type of First Transplant
Single (Never married) 63 52.1% 58 47.9%
Married 304 56.8% 231 43.2%
Living with partner (Cohabitating) 18 64.3% 10 35.7%
Divorced (Divorced or separated) 52 48.8% 34 39.5%
Widowed 11 61.1% 7 38.9%
Married 304 56.8% 231 43.2%
Not married 144 56.9% 109 43.1%
Northeast 110 58.2% 79 41.8%
Midwest 93 54.7% 77 45.3%
South 146 52.7% 131 47.3%
West 99 65.1% 53 34.9%
Excellent 77 54.6% 64 45.4%
Very Good 140 54.0% 119 45.9%
Mostly Good 115 60.8% 74 39.2%
Good 43 51.8% 40 48.2%
Fair 39 61.9% 24 38.1%
Challenging 28 60.9% 18 39.1%
Poor 4 80.0% 1 20.0%
One 364 56.8% 277 43.2%
Two 68 52.7% 61 47.3%
Three 12 92.3% 1 7.7%
Four 2 66.7% 1 33.3%
Five 1 100.0% 0 0.0%
Six 1 100.0% 0 0.0%
Kidney 243 56.3% 189 43.8%
Kidney-Pancreas 15 46.9% 17 53.1%
Heart 60 55.6% 48 44.4%
Heart-Lung 5 83.3% 1 16.7%
Liver 97 57.4% 72 42.6%
Pancreas 5 45.5% 6 54.5%
Double Lung 20 69.0% 9 31.0%
Single Lung 8 66.7% 4 33.3%
Intestine 6 50.0% 6 50.0%
59
Table 4-9.  Comparison of CAM users and non-users in study
Users % of total Non-users % of total
Time Since Last Transplant Surgery
Less than 1 year 26 60.5% 17 39.5%
1 to <2 years 69 57.0% 52 43.0%
3 to <5 years 72 58.5% 51 41.5%
5 to <10 years 113 54.9% 93 45.1%
10+ years 167 57.0% 126 43.0%
 Table 2-2, which highlights the correlates of CAM use among adults in four national 
studies, is reprinted below for comparison.  It shows that CAM users in these national 
populations tend to be female, younger, not black, not poor, more highly educated, and 
residents in the Western states.  Although study numbers were too small to assess race as a 
factor and CAM was used fairly evenly across income levels, the transplant recipient sample 
generally supported findings with respect to gender, age, education, and residence.
Table 2-2. Positive correlates of CAM use among U.S. adults in four national studies
Eisenberg (1991) Eisenberg (1997) NHIS (2002) NHIS (2007)
1. Gender None Female Female Female
2. Age 25-49 y.o. 35-49 y.o. 30-69 y.o. 30-69 y.o.
3. Race Non-black Non-African American Varied by therapy None
4. Income 2. Age >$50,000 Not poor* Not poor*
5. Education Some college or more Some college or more More than high school More than high school
6. Residence Living in the West** Living in the West** Living in the West** Living in the West**
7. Smoking 
history N/A N/A Former smoker Former smoker
8. Hospitalization N/A N/A Hospitalized in last year Hospitalized in last year
9. # of Doctor 
Visits N/A N/A Greater number Greater number
10.  # of Health 
Conditions N/A N/A Greater number Greater number
*Family income > poverty threshold           **WA, OR, CA, NV, NM, AZ, ID, UT, CO, MT, WY, AK, and HI
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 A binary logistic regression was performed to test for predictive factors for CAM use 
in this population.  Table 4-10 shows that gender and education are positively correlated with 
CAM use with Exp(B) values of <.05.  None of the other independent variables correlates 
statistically and significantly with CAM use, but the third most powerful association is 
between health status and CAM use.  Neither insurance coverage nor marital status have a 
bearing on CAM use.
Table 4-10.  Regression analysis
Variables in the Equation
B S.E. Wald df Sig. Exp(B)
95% 
C.I.for 
EXP(B)
Lower Upper
Step 1a Gender 0.349 0.151 5.363 1 0.021 1.418 1.055 1.906
Married -0.084 0.177 0.225 1 0.635 0.920 0.651 1.300
Education -0.244 0.076 10.303 1 0.001 0.783 0.675 0.909
Income 0.062 0.068 0.826 1 0.363 1.064 0.931 1.216
Health Status -0.071 0.052 1.861 1 0.172 0.931 0.841 1.032
Insurance -0.119 0.501 0.056 1 0.812 0.888 0.332 2.371
Time since Tx 0.054 0.059 0.835 1 0.361 1.055 0.940 1.185
NHIS age group -0.117 0.221 0.278 1 0.598 0.890 0.577 1.373
# of transplants -0.163 0.148 1.202 1 0.273 0.850 0.636 1.137
Type of donor 0.113 0.152 0.553 1 0.457 1.120 0.831 1.508
Constant 0.638 0.913 0.489 1 0.484 1.893
a Variable(s) entered on step 1: Gender, Married, Education, Income, Health, Insurance, Time since last transplant 
surgery, NHIS age group [30-69 y.o.], Number of of transplants, Type of donor [living or deceased].
Key IHC Findings
 This study also assessed if solid organ transplant recipients utilize integrative health 
care, whether they desire it, and what their preferences for it may be.   Subjects were asked 
the following four (4) questions—created for this study—about their use of and preferences 
for integrative health care: 
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1. Does someone (inc. yourself) currently integrate/facilitate the combining of your 
conventional and non-conventional care?  [Yes/No]
2. [If Yes] Please rank each person who helps facilitate your integrative care in order of her/
his involvement. You need only rank as many as apply, and if no one helps you then please 
mark "No one".
- Medical doctor 
- Nurse
- Dietician/Nutritionist
- Alternative provider(e.g., chiropractor, naturopath)
- I do it myself 
- No One
- Other
- If you ranked "Other", who is "Other"?
3. Would you want someone who knows about both conventional medicine and non-
conventional practice to serve as an integrator for your care?  [Yes/No]
4. [If Yes] Would you want this integrator to be any of the following (please rank up to top 
five, only as many as apply):
- Psychologist/Social worker 
- Pharmacist
- Dietician/Nutritionist
- Doctor of Osteopathy (D.O.)
- Medical doctor (MD, including specialists and psychiatrists)
- Physician Assistant (PA), Nurse (RN), or Nurse practitioner (NP)
- Dentist
- Alternative provider like an acupuncturist or chiropractor)
- A trained integrator who has knowledge of conventional and complementary therapies
- Me
- Someone else
- If you ranked "Someone else", who is "Someone else"?
Not all 788 subjects responded to the above questions on IHC, and not all who answered one 
question completed the others.  This is the reason for the varying denominators in the 
following findings.  Table 4-11 lists subjects’ responses to Questions #1 and #3 asking 
whether they currently have someone integrating their care and whether they want someone 
to do so.    
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Table 4-11.  Current and desired integrators of care
Whole 
Population N=788 CAM Users n=448
Non-CAM 
Users n=340
Have an integrator 23.9% 169 of 707 36.4%
147 of 
404 6.5%
22 of 
303
Want an integrator 49.6% 390 of 787 55.3%
247 of 
447 42.1%
143 of 
340
 Table 4-12 lists the integrators identified by respondents who said they have someone 
who integrates their care.  This question was difficult to tabulate because many subjects left it 
completely blank or partially blank (e.g., ranked one or two choices only).  The response total 
for the whole population was 193 and the response total for CAM users was 166.  The sum of 
the numbers in the second and fourth columns do not equal 788 and 448 because of the 
missing responses.  The top choices are bolded.
Table 4-12. Current primary integrators for study population and CAM users
Integrator Whole Population CAM Users
N=193 % n=166 %
Medical doctor 39 20.2% 30 18.1%
Nurse 5 2.6% 3 1.8%
Dietician/Nutritionist 1 0.5% 1 0.6%
Alternative provider (e.g., 
chiropractor, naturopath) 10 5.2% 7 4.2%
I do it myself 96 49.7% 89 53.6%
No One 20 10.4% 17 10.2%
Other 4 2.1% 3 1.8%
 Findings reveal that nearly half (49.7%) of the transplant recipients in the study 
population serve as their own integrators of CAM and conventional care, and over half 
(53.6%) of CAM users do so.  Physicians are the second-highest integrator, with about one in 
five subjects listing their medical doctors as integrators of care.  Despite the fact that CAM 
users are, by definition, those who have utilized at least one form of CAM therapy in the last 
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year, most do not see their CAM providers as integrators.   “Other” integrators include:  
“Jesus Christ, Father, and Spirit” (1), wife (1), husband (1), and daughter (1).
 Regarding IHC preferences, when subjects were asked whether they would like an 
integrator, the total population was split:  49.6%  stated they would like someone to serve in 
that capacity.  In contrast, 55.3% of CAM users stated that they desired an integrator of care.  
Figure 4-2 presents the data from Table 4-11 in a graphic form that illustrates the three 
groups’ current integrator status and desired integrator status. 
 
 When subjects were asked who they would prefer to integrate their care, they 
responded as shown in Tables 4-13 and 4-14.  Respondents ranked their top five (5) 
integrators in order of preference; the top two are bolded in each table.
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Figure 4-2.  Current and desired integrators of care
Table 4-13. Desired primary integrators for study population
Desired Integrator
Ranked 
#1 %
Ranked 
#2 %
Ranked 
#3 %
Psychologist/Social workers 9 2.3% 13 3.3% 15 3.8%
Pharmacist 11 2.8% 27 6.9% 34 8.7%
Dietician/Nutritionist 13 3.3% 33 8.5% 58 14.9%
Doctor of Osteopathy (DO) 13 3.3% 28 7.2% 16 4.1%
Medical doctors (MD, inc. 
specialists and psychiatrists) 183 46.9% 63 16.2% 39 10.0%
Physician Assistant (PA), Nurse 
(RN), or Nurse practitioner (NP) 13 3.3% 92 23.6% 58 14.9%
Dentist 0 0.0% 4 1.0% 3 0.8%
An alternative provider, like an 
acupuncturists or chiropractor 5 1.3% 16 4.1% 18 4.6%
A trained integrator who has 
knowledge of conventional and 
complementary therapies
83 21.3% 42 10.8% 39 10.0%
Me 35 9.0% 33 8.5% 29 7.4%
Someone else 4 1.0% 3 0.8% 5 1.3%
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Table 4-14. Desired primary integrators for CAM users
Desired Integrator
Ranked 
#1 %
Ranked 
#2 %
Ranked 
#3 %
Psychologist/Social workers 6 2.4% 5 2.0% 13 5.3%
Pharmacist 5 2.0% 14 5.7% 24 9.7%
Dietician/Nutritionist 9 3.6% 17 6.9% 29 11.7%
Doctor of Osteopathy (DO) 6 2.4% 18 7.3% 9 3.6%
Medical doctors (MD, inc. 
specialists and psychiatrists) 109 44.1% 44 17.8% 27 10.9%
Physician Assistant (PA), Nurse 
(RN), or Nurse practitioner (NP) 8 3.2% 58 23.5% 33 13.4%
Dentist 0 0.0% 1 0.4% 0 0.0%
An alternative provider, like an 
acupuncturists or chiropractor 4 1.6% 12 4.9% 16 6.5%
A trained integrator who has 
knowledge of conventional and 
complementary therapies
59 23.9% 30 12.1% 24 9.7%
Me 27 10.9% 24 9.7% 20 8.1%
Someone else 3 1.2% 2 0.8% 5 2.0%
 Respondents identified medical doctor as their integrator of choice, followed by a 
trained integrator who has knowledge of conventional and complementary therapies.         
Physicians (bolded) were ranked as either the first or second choice as integrator for 63.1% 
of the study population and 61.9% of CAM users.  Physician assistants/nurses/nurse 
practitioners (bolded) garnered the most Number Two ranks in both groups.  Because of the 
similarity in the number of subjects who ranked trained integrator as their first choice and 
physician assistant/nurse/nurse practitioner as their second (59 and 58, respectively), 
66
responses were checked to see if these ranked by were the same people.  Only six (6) 
respondents fell into this category.
 It should be noted that there does not exist a formal “integrator” role in the health care 
system—with the exception of integrative medicine physicians who are often trained in 
multiple CAM therapies and perhaps others who work in IHC clinics—and this choice was 
included to test subject interest.  These findings hint at the levels of trust and responsibility to 
which solid organ transplant recipients hold medically-trained providers for their care.  
Qualitative data collected on what this population deems important in IHC confirm this.  
Valued Components of IHC
 One of the final questions subjects were asked was: “What would be important to you 
if you were seeing an integrative health care provider?”  The qualitative data collected from 
this query highlight the qualities, skills, and attributes this population considers important in 
IHC providers and IHC in general.  Their responses were analyzed and coded by topic.  Of 
the 788 responses, 85 (10.7%) marked this as “not applicable”, 61 (7.7%) said they “don’t 
know”, 69 (8.8%) replied that they would not use IHC, and 573 (72.7%) shared their 
opinions.  Table 4-14 lists their responses by frequency, with each topic weighted equally 
(i.e., not prioritized in the order provided in the open-ended text box).
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Table 4-15. Desired qualities, skills and attributes sought in IHC providers
Attribute sought
Number of 
responses %
Knowledge/Expertise 133 23.2%
Preserves graft (transplanted organ) health 123 21.5%
Improves health 69 12.0%
Believes in team concept 55 9.6%
Offers scientific proof 50 8.7%
Helps navigate the health care system and IHC 28 4.9%
Listens 25 4.4%
Includes, agrees with and puts patients first 25 4.4%
Trust 24 4.2%
Has holistic philosophy 23 4.0%
Provides high quality of care 21 3.7%
Experienced/Success 19 3.3%
Affordable 18 3.1%
Communicates with other providers 18 3.1%
Insurance coverage 16 2.8%
Knows effects of CAM 13 2.3%
Certification 12 2.1%
Educates 12 2.1%
Reputation/References 10 1.7%
Ensures safety 9 1.6%
Referrals from other MDs or recipients 8 1.4%
Helps decrease current side effects 8 1.4%
Helps with nutrition 8 1.4%
Provides coordination 8 1.4%
Helps decrease medications 7 1.2%
Current with research 6 1.0%
Helps with stress 6 1.0%
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Table 4-15. Desired qualities, skills and attributes sought in IHC providers
Attribute sought
Number of 
responses %
Access 6 1.0%
Ethical/Honest 5 0.9%
Spends time with patient 5 0.9%
Offers new perspectives/options/insights 5 0.9%
Convenience/Accessibility 4 0.7%
Personally experienced IHC 3 0.5%
Helps with pain 3 0.5%
Helps with weight 3 0.5%
Helps with exercise 3 0.5%
Provides a plan 3 0.5%
Professional 2 0.3%
Kind, caring, compassionate 2 0.3%
Helps with anxiety 2 0.3%
Helps with emotional aspects 2 0.3%
Knows financial aspects 2 0.3%
n=573 respondents
 Another way to view the qualitative results is in the Figure 4-3, which clusters the 
topics by aspect of IHC groups:
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This figure highlights the different characteristics and attributes study participants value in 
IHC providers and IHC as a field.  First and foremost is that IHC providers possess 
knowledge and expertise in both CAM and conventional medicine (e.g., “[s]omeone who 
knows what they are doing in both arenas”).  They also want providers who:  give them 
scientific proof of IHC and CAM efficacy, work as a team with their other providers, include 
them as integral team members, help them navigate IHC, and have a holistic philosophy of 
health.  Additionally, subjects want providers who will improve their health, who provide 
quality care, who listen to them, and whom they can trust.  These top priorities capture both 
the practical and human aspects of IHC and health care in general, and they highlight not 
only what this group of transplant recipients seeks in IHC providers but what they value (and 
perhaps desire) in current providers.  
Figure 4-3. Desired qualities, skills and attributes sought in IHC providers by groups
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 However, transplant recipients in this study show that graft health far outweighs 
everything else in what they value in receiving in IHC.  The following two responses 
succinctly express this opinion and were echoed by 121 others:
First is the health of my transplanted organ.  Next would come my overall health and 
fitness concerns.
To insure [sic] that the complementary therapies would not be contraindicated.  My 
top priority is the maintenance of my life saving transplant. 
This emphasis on graft survival is telling because it reveals that recipients view their 
transplant surgeries as successful and life-saving medical interventions, the responsibility 
they feel about ensuring the organ(s)’s function, and why they value conventional medicine, 
procedures, and providers.  
 As noted in the above section, “Key IHC Findings”, 61.9% of respondents ranked 
their medical doctors as the first or second desired integrator of their care.  Although 
transplant recipients in this study use CAM therapies at higher rates than the general 
population, this use may be tempered, enhanced, or determined by graft health and their 
transplant team.  Data collected in this study do not allow for these relationships to be 
studied.
Discussion
 The goals of this study were to assess CAM use by this understudied population of 
high users of the medical system, compare results with national findings, and examine 
subjects’ preferences for IHC as directed by the three (3) stated hypotheses.  The first 
hypothesis is stated below:
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H1 = Solid organ transplant recipients will use CAM at higher rates than the 
general population.
This research showed that solid organ transplant recipients in the study use CAM at a higher 
rate (56.9%) than the national general population (38.3%).  Although data were collected 
from a convenience sample of transplant recipients who responded to widespread calls for 
participation, the respondents represent a sample size of this population larger than 
previously studied.  
 That being said, the sample size was still too small to test whether factors such as race 
were associated with CAM use, examine subjects’ use of individual CAM therapies, or look 
at other sub-demographic factors.  Because health status was self-reported, it was also not 
possible to examine possible associations between CAM use and health outcomes.  It would 
be interesting to build upon this study and see whether clinical documentation of health status 
matches up with self-reported status by the recipients and how this compares with CAM use.
 This study shows that solid organ transplant recipients are willing to share their 
experiences and opinions about health care,10 that online surveys are an effective means for 
collecting data with this population, and that there is a complexity to solid organ transplant 
recipients’ beliefs and behaviors that might be clarified in focus groups and by cross-
referencing with medical charts.  Focus groups or key informant interviews might also 
increase understanding about predictors for CAM use by this population, an issue tested by 
the second hypothesis.
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10 In fact, this researcher’s committee chair was fielding 2-3 calls a day during the data collection period from 
transplant recipients who wanted to personally share their health experiences with him.
 This study’s second hypothesis, H2, refers to the CAM Healthcare Model, which was 
first described in Chapter Three.  Figure 3-1 is reprinted below for reference.
H2 = Select predisposing, enabling, and need for care factors will predict 
CAM use for solid organ transplant recipients.
 The regression analysis showed that the only predictive factors for CAM use for this 
population were female gender and higher education level, which are predisposing factors in 
the CAM Healthcare Model.  Therefore, this hypothesis was not validated because no 
enabling (e.g., income, geographic location) or need for care (e.g., perceived health status) 
factors were shown to be predictive.  Part of the reason for this lack of validation is that not 
enough factors were measured and tested in the study.
Figure 3-1.  CAM Healthcare Model
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 While the CAM Healthcare Model includes a multitude of factors that can contribute 
to health care use of all kinds, it depicts these factors in a linear, unilateral progression 
toward health service use.  The quantitative and qualitative findings in this study only begin 
to touch on the complexity and multifaceted reasons why people may or may not seek and 
use CAM therapies.  For example, the second-most cited reason why subjects used CAM in 
the last year was don’t know, which accounted for nearly one in eight (12%) of the reasons 
for CAM use for all health conditions.  Although the research design—collecting data using 
an online survey—did not allow for immediate clarification of the don’t know response or 
follow-up at a later time, the ambiguity of subjects’ responses reveals a level of abstractness 
related to seeking CAM.  
 Complementary and alternative medicine researchers have argued that it is difficult to 
measure the efficacy of CAM therapies using randomized controlled trials (RCT), which are 
considered the gold standard for measuring the effectiveness of clinical treatment and in 
evidence-based medicine.  The reasons cited include:  blinding “distorts the therapeutic 
situation and introduces unknown psychologic factors into the interaction between 
practitioner and patient” (Walach, 2003, p. 10), RCTs evaluate efficacy based on a 
framework of medical treatment that does not include other paradigms/systems for diagnosis 
and treatment (H. MacPherson, Sherman, K., Hammerschlag, R., Birch, S., Lao, L., & 
Zaslawski, C., 2002), and the methodology of RCTs can negatively affect the quality of 
administered CAM treatment (H. MacPherson, Sherman, K., Hammerschlag, R., Birch, S., 
Lao, L., & Zaslawski, C., 2002).  
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 The holistic nature of CAM makes it difficult to control for all the factors related to 
some therapies’ effectiveness, which is the same argument West et al. (2008) make in their 
push for causal inference designs as an alternative to RCTs when examining multifaceted 
public health studies (e.g., the effect of Hurricane Katrina on medical care and HIV risk 
behaviors).  Therefore, in order to better understand CAM use, the CAM Healthcare Model 
could be improved by incorporating multiple layers of factors with a goal of showing causal 
inference rather than predicting actual use or outcome.  
 Such a “three-dimensional” model could account for the uniqueness of different 
populations and the factors that affect their use of CAM, much like the value transplant 
recipients place on graft health.  This type of model could then be tested for both CAM and 
IHC use.
 The third hypothesis shifted from CAM use to patient preference for integrative 
health care:
H3 = Solid organ transplant recipients will want someone who knows about 
both conventional medicine and non-conventional practice to serve to 
integrate their care.
This study creates a benchmark of patient preferences for IHC findings, and it revealed that 
many solid organ transplant recipients do want trained integrators for their care.  Nearly half 
of the study population (49.6%) indicated that they would “want someone who knows about 
both conventional medicine and non-conventional practice to serve as an integrator for your 
care”.  Among those who used CAM within the 12 previous months, this affirmative 
response increased to 55.3%, which confirms H3.  The expressed desire for integrators 
suggests the value patients place on someone to help them safely navigate through the 
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choices that IHC offers and also the maze that this arena represents.  However, the fact that 
nearly half of all respondents—whether CAM users or not—do not want an integrator 
warrants additional research and additional questioning to find out more specifically what 
patients seek in health care and with what they are currently satisfied.
 Study findings also highlight the importance recipients place on their overall health, 
the quality of care sought, and the responsibility patients place on physicians.  For this 
particular population, health of transplanted organ(s) may be an underlying factor related to 
their use of CAM and IHC.  It is possible this population may differ from other populations 
of people living with chronic conditions (e.g., cancer, HIV/AIDS) in that transplant recipients 
have already received a life-saving medical intervention that worked.  It would be 
worthwhile to compare transplant recipient attitudes and behaviors with cancer survivors and 
see whether there are similarities in their approaches to care and values. 
Study Limitations
 Once again, this study collected data from a convenience sample of solid organ 
transplant recipients with access to computers and the internet and who were somehow 
connected to an existing transplant community.  This may have skewed the population 
towards those with higher incomes, educational levels, and willingness to help others by 
taking an online survey.  It is again important to note that this is a self-selecting population of 
individuals who chose to participate in this study.  
 In addition, the study did not involve live interviewers to make sure questions were 
understood by subjects; formatting limitations in the online survey service did not allow 
subjects to go back to previous questions once they answered them (so answers could not be 
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changed); a drawing of small incentives was offered to those who completed the survey; and 
participants were asked to recollect past behaviors and reasons for them.
 This study also excluded transplant recipients who do not read or write English from 
participation.  The result was a population that skewed Caucasian (84.5% of the total), with 
Latinos making up a mere 4.3% of the group.  This exclusion means that the sample 
population is not representative of the national transplant recipient population (2005-2009), 
which is 61.9% Caucasian and 12.9% Hispanic ("Organ Procurement and Transplantation 
Network online database," 2010).11
 As shown in Table 4-1, only 6.4% of the study population rated their health status as 
challenging or poor compared to 13.2% of the larger NHIS sample.  It is therefore possible 
that poor health may have also limited transplant recipients’ ability to participate.  Transplant 
recipients experiencing health problems may be more concerned with taking care of 
themselves and less inclined to take surveys.   
 Finally, the consent letter on the first page of the online study stated that this research 
focused on CAM use by patients.  It is possible that transplant recipients who have used or 
would be willing to use CAM therapies self-selected to participate in this study.  Similarly, 
those who have no interest in or experience with CAM may have opted to not participate in 
the study.
 Despite limitations, participation and response rates for the study were high and this 
research revealed new findings with potentially significant policy implications.  The final 
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11 The rest of the national transplant recipient population (2005-2009) was:  African-American (19.4%), 
American Indian/Alaska Native (0.7%), Pacific Islander (0.3%)  Asian (4.5%), and Multiracial (0.6%).
chapter will present them within the context of next steps that should be taken to improve 
care for transplant recipients.
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Chapter Five - POLICY IMPLICATIONS AND PLAN FOR CHANGE
 As stated in the first chapter, the purpose of this study was to examine the utilization 
of complementary and alternative medicine (CAM) by solid organ transplant recipients in the 
United States and their preferences related to integrative health care (IHC).  This study was 
the first to survey a large (400+) sample of United States solid organ transplant recipients on 
CAM and IHC behavior and values.  Findings shed light on what types of health conditions 
for which transplant recipients seek additional care, the kind of care they desire, what they 
value in health providers, and how their health care experiences extend beyond conventional 
medicine. 
 Subjects’ self-stated behavior, values, and perspectives provide documentation that 
can help improve transplant care.  The study's findings do not in themselves lead to a clear 
plan for change in policy or practice, but this final chapter details how the findings point 
toward six next steps that should be taken to help ensure the efficacy of health care for the 
nation's solid organ transplant recipients. 
Step #1: Policy
 The seminal National Organ Transplantation Act of 1984 (NOTA) established federal 
oversight of organ donation and transplantation activities in the United States.  It also called 
for the creation of a Task Force on Organ Procurement and Transplantation to conduct a 
comprehensive assessment and make recommendations for an ethical and efficacious organ 
procurement and transplant system.  This legislation, the ensuing Final Rule (1999),12 and its 
amendment, the Organ Donation and Recovery Improvement Act (2004), address how to best 
use the scarce resource of organs to save lives through transplantation.  These federal 
legislative and regulatory acts focus on the following priorities:
• prohibiting the purchase of organs,
• increasing the number of organs available for donation (through increasing public 
awareness, procurement processes, and living donation), 
• improving the viability of procured organs (from recovery and preservation to 
transplantation), 
• developing and maintaining fair systems for allocation of recovered organs, and 
• increasing knowledge and practice through research.  
However, increasing graft and transplant recipient survival rates is not an included goal, nor 
is improving recipient quality of life or ensuring safety in and quality of post-transplant care 
for recipients.
 If the overarching goal of this federally-created and -regulated system is to save lives 
through organ transplantation, then federal policy cannot be limited to just one side of the 
equation.  While increasing the nation’s supply of organs is a viable solution for a public 
health problem (i.e., organ failure) and working to improve the viability of these organs for 
transplantation is a priority, it is equally important that there exists federal policy to improve 
the viability of organs after they are transplanted.  Given the high prevalence of CAM use by 
transplant recipients, policymakers need to include the use of CAM (and related issues) in 
maintaining and improving health of post-transplant patients.
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12 TITLE 42—Public Health, Chapter I—Public Health Service, Department of Health and Human Services, 
Subchapter K—Health Resources Development, PART 121--ORGAN PROCUREMENT AND 
TRANSPLANTATION NETWORK
Step #2: Clinical Care
 There are no standardized clinical guidelines for post-transplant care.  This is in part 
because the science, technology, and art of transplantation evolve quickly 13 and reasons for 
graft loss are different between types of organs and conditions.14  It is also because there is 
no federal call for it.  The current system leaves the development of acceptable standards of 
practice to individual transplant centers and professional clinical societies, and it works 
through self- and peer-monitoring along with Medicare Conditions of Participation.  
However, patients (and their transplanted organs) could benefit from the development of 
more formal and universal guidelines for care that maintain the integrity of this field.
 One recommendation specifically related to the finding that transplant recipients use 
CAM at higher rates than the general population is for the Organ Procurement 
Transplantation Network (OPTN), the quasi-agency created by NOTA (1984) and charged 
with overseeing the national transplant system, to develop policies to improve aftercare for 
transplant recipients.  These policies should include integration of questions of CAM use in 
follow-up care, language for cross-discipline communication, and the addressing of 
conditions and concerns (e.g., anxiety, weight, stress) for which subjects seek care but might 
not be included in current medical workups.  Policymakers and providers need to know how 
best to deliver the kinds of care sought by transplant recipients.
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13 J. Bowman and R. Durbin, personal communication, December 16, 2010.
14 G. McNatt, personal communication, December 20, 2010.
Step #3: Training
 Health care providers—primarily MDs, DOs, PAs, and NPs—should receive training 
in how to improve their effectiveness as integrators of CAM and conventional medicine.  
Examples of possible education programming for transplant professionals include: 1) 
modules that provide overviews of CAM therapies, basic CAM and IHC issues, and 
medication and herb interactions, 2) introductions to/networking with CAM providers in their 
areas, and 3) collaborative sessions to develop standards of language, reporting, and referrals 
across disciplines.  
 The Organization for Transplant Professionals (more commonly known as NATCO), 
could work with schools of integrative health care to include such modules and session into 
their continuing education programs with the goal of improving how practitioners relate to 
recipients and long-term outcomes for this group.  In order for this to happen, there must be 
national recognition that transplant recipients are using CAM alongside conventional 
medicine and greater understanding of how this occurs.  
Step #4: Patient-Provider Communication
 What roles can and do transplant recipients play in this discussion?  If their survival is 
the goal of this national transplant system, then where do they fit into it?  Patients are often 
the passive players in the health care system even though they are its centerpiece.  
 This study revealed that transplant recipients seek CAM care outside of the medical 
system—which provided the life-saving intervention—sometimes for health concerns either 
not addressed or not adequately addressed by conventional medicine.  In order to better 
understand patient needs, local, regional, and national forums could be established to capture 
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patient perspectives and get them more involved in their own health care.  City, county, and 
state governments could work alongside the Division of Transplantation (HRSA) and 
national transplant-related health organizations (e.g., National Kidney Foundation, American 
Liver Foundation) to increase communication lines between patients, providers, and 
policymakers.
 On a more local level, transplant recipients in this study voiced the importance they 
place on being an integral part of their own health care team, being heard, and establishing 
trust with their providers.  Policies set by transplant centers (or the hospitals in which they 
are housed) to encourage greater communication between patient and provider and to 
integrate questions related to CAM, IHC, and “additional concerns” in patient workups 
would address patients’ cited needs and allow for a broadening of scope of practice that can 
be viewed as more patient-centered.
Step #5: Additional Research
 This study provides a baseline understanding of CAM use by solid organ transplant 
recipients in the United States and highlights the need for additional research that will 
increase knowledge about the correlates and factors related to CAM use in this population.  
As mentioned at the end of the discussion on the third hypothesis (p. 76), transplant 
recipients comprise a unique population whose members have already received a life-saving 
medical intervention that requires continuing medical treatment.  Replication of the IHC 
section of this study’s survey with other patient populations could help determine whether 
transplant recipients preferences for IHC are unique to them.  It may also increase 
understanding into the reasons why patients seek CAM.
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 In order to increase understanding of patient use of CAM and IHC, research funding 
must be increased.  The Organ Donation and Recovery Improvement Act (2004) authorized 
$2 million a year for five (5) years of funding to include “[s]tudies relating to organ donation 
and the recovery, preservation, and transportation of organs.”  As noted in the Step #1 (this 
chapter), there is no mention of long-term care or outcomes of patient or graft.  Policies set 
by Congress and federal agencies—such as the Agency for Healthcare Research and Quality 
(AHRQ) and the Division of Transplantation (DoT) at the Health Resources and Services 
Administration (HRSA)—could broaden the scope to include CAM, IHC, aftercare, and 
long-term outcome transplant research.  Policymakers must be reminded of the overarching 
goal of transplantation, which is to save people’s lives.
Step #6: Specific Strategy for Collaboration
 The omission of an emphasis on improving aftercare for transplant recipients in 
legislation, policy, and practice has been discussed.  One additional barrier to improving 
long-term recipient outcomes is the lack of a reimbursement vehicle to provide such 
aftercare.  Transplant centers generally absorb the cost of providing follow-up visits for 
transplant recipients (and living donors).  While transplant surgeon and specialist (e.g., 
nephrologists, cardiologists) visits can be billed as physician costs, those for nurses, aides, 
and administration are not.  Many transplant centers provide some sort of follow-up care for 
recipients because it is in the best interest of the patients and the program to keep them 
healthy, but the practice is not mandated, standardized, or covered.  
 This issue was discussed during a telephone conversation with Mr. Richard Durbin 
and Dr. James Bowman, Director and Medical Director, respectively, of the Division of 
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Transplantation (HRSA) at U.S. Department of Health & Human Services.15  They confirmed 
that while no federal legislation or regulations emphasize recipient aftercare, it would be 
difficult to implement any because the federal government generally does not provide 
mandates related to procedures.  However, the government is interested in populations living 
with specific diseases and their clinical outcomes, and federal legislation can be directed 
around outcomes like the long-term health of transplant recipients versus success rates of 
procedures like transplantation. 
 The proposed strategy for action is therefore for stakeholders in the transplant system
—federal agencies, local governments, transplant professionals, non-profit health 
organizations, payers, patients and families—to collaborate and plan a coordinated initiative 
to obtain recognition of solid organ transplant recipients as a special chronic disease 
population for inclusion in the rollout of patient-centered medical home demonstration 
projects under the Patient Protection and Affordable Care Act (PPACA) of 2010.
 A patient-centered medical home is “a health care setting that facilitates partnerships 
between individual patients, and their personal physicians, and when appropriate, the 
patient’s family.  Care is facilitated by registries, information technology, health information 
exchange and other means to assure that patients get the indicated care when and where they 
need and want it in a culturally and linguistically appropriate manner” ("PPC - Patient-
Centered Medical Home," 2011).  The Patient-Centered Primary Care Collaborative’s 2007 
“Joint Principles of Patient-Centered Medical Homes”16 includes values compatible with 
IHC:
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15 J. Bowman and R. Durbin, personal communication, December 16, 2010.
16 The full list, with expanded descriptions, is found in Appendix D.
• Personal physician 
• Physician-directed medical practice...leading a team
• Whole person orientation 
• Care is coordinated and/or integrated across all elements of the complex health care 
system
• Quality and safety are hallmarks of the medical home
• Enhanced access to care is available
• Payment appropriately recognizes the added value provided to patients who have a 
patient-centered medical home
 Aftercare provided for transplant recipients in the medical home model would be 
patient-centered, team-delivered, and reimbursable; focus on long-term health outcomes; 
could allow for interdisciplinary/IHC team care; and improve upon the current patchwork of 
post-transplant care.  Improved aftercare for transplant recipients could actually increase the 
availability of organs for transplantation in other candidates:  a primary goal of providing 
aftercare for transplant recipients in the medical home model would be to improve graft 
survival by improving recipient health through coordinated, long-term, and covered care.  In 
other words, the provision of this model could increase graft survival rates while decreasing 
graft failure rates and the need for re-transplantation.  
 If more transplant recipients are able to successfully keep their grafts, they would not 
need additional transplants and more organs would be made available for other candidates on 
the national waiting list.  This model therefore fits into the current provisions of the 
legislation (Final Rule, 1999)—to increase the availability of organs for transplantation—
with which the Department of Transplantation (DoT) is charged.
  The DoT has had success with increasing the number of organs available for 
transplantation through its Breakthrough Collaborative that focused on increasing conversion 
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rates of potential donors and the number of organs recovered per donor.   It is because of its 
history of accomplishment and its role in the transplant field that the DoT should be the 
agency that takes the lead in the collaborative effort proposed here.  Although nothing formal 
was discussed, there was positive feedback of this initial idea during the previously-
mentioned telephone conversation with Mr. Richard Durbin and Dr. James Bowman (DoT 
Director and Medical Director).   The argument for including the transplant recipient 
population in medical home demonstration projects was “something quite important.”17
 The DoT’s groundbreaking and comprehensive Breakthrough Collaborative was 
made possible because it had the personal backing of then-Secretary of Health and Human 
Services Tommy G. Thompson in the early- to mid-2000s.  It would be imperative to gain the 
support of the current Secretary of Health and Human Services, Kathleen Sebelius, and the 
head of the Centers for Medicare & Medicaid Services (CMS), Donald Berwick,18 for the 
proposal.  
 The transplant community is comprised of multidisciplinary health care providers,  
administrators, government representatives, policymakers, payers, patients, families and 
other stakeholders, who have a history of collaboration and open dialogue.  Part of this may 
be the result of NOTA (1984), which established the Task Force on Organ Procurement and 
Transplantation and mandated that its membership (and that of all organ procurement 
organization boards of directors) must be representative of the broad spectrum of 
stakeholders.  Likewise, OPTN/UNOS committees, which review and revise policies related 
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17 J. Bowman and R. Durbin, personal communication, December 16, 2010.
18 Dr. Berwick was the founder and previous head of the Institute for Healthcare Improvement, which  created 
the Breakthrough Collaborative.
to organ donation and transplantation, include members from varying stakeholder groups, 
including those who are transplant recipients, living donors, donor family members, and from 
the general public.  
 Because of this history of working together, the proposed strategy is a viable 
recommendation.  This study highlighted the willingness of transplant recipients to share 
their experiences, the value they place on preserving the health of their transplanted organs, 
and the faith they have in the health care system.  With strong DoT leadership and support 
from other leading transplant organizations, this strategy for collaboration can improve care 
for solid organ transplant recipients in the United States and take a big step in ensuring the 
health and sustainability of the sizable investment made in organ donation and 
transplantation.
Final Thoughts
 The social determinants of health model highlights the many- and multi-layered 
factors that contribute to an individual’s and a population’s health and well-being.  As the 
World Health Organization (WHO) states, “The social determinants of health are the 
conditions in which people are born, grow, live, work and age, including the health system. 
These circumstances are shaped by the distribution of money, power and resources at global, 
national and local levels, which are themselves influenced by policy choices” (WHO, 2011).  
This extends beyond a medical model to include such factors as environmental and living 
conditions, access to preventive and treatment services, and public health policies.  Dahlgren 
and Whitehead’s visual representation ("Determinants of Health," 2005) is shown below in 
Figure 5-1.
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 The Patient Protection and Affordable Care Act (PPACA) of 2010 similarly 
repositions the framework of the nation’s health care system and emphasizes prevention, 
outcomes, and comparative effectiveness.  First Lady Michelle Obama’s Let’s Move 
campaign to prevent childhood obesity and “to raise a healthier generation of kids” is 
representative of this multi-pronged and holistic approach to improving population health.  In 
the same way, the steps outlined in the above section propose a whole-spectrum approach to 
improving the U.S. organ donation and transplantation system.  
 If policies that provide for the care of organs—from donation through transplantation 
and life of the organ(s)—are enacted alongside the development of mechanisms to pay for 
coordinated, multidisciplinary aftercare for transplant recipients, then the entire system will 
benefit from the improved survival rates of transplanted organs, increased number of donated 
organs for transplantation, improved health of transplant recipients, and financial savings 
Figure 5-1.  Social Model of Health (Dahlgren and Whitehead, 1991) 
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from successful transplantation.19  Such policies and practices align with both the PPACA 
(2010) and the social determinants of health model.
 Another way to look at how the proposed recommendations fit with sound public 
health practice and recent health reform legislation is to examine the Native Hawaiian 
ahupua‘a land division system.  Islands were divided into “pie slices” that ran from the 
mountains to the sea and were based on watershed boundaries.  Each of these ahupua‘a was 
a self-sufficient community in which residents who lived near the ocean shared fish, those 
who resided in the mountains shared hunted boar, and people who farmed in the valley 
shared kalo (taro) freely with each other.  Water flowly from the mountains was diverted to 
grow crops and then redirected back to the streams to return to the ocean.  An ahupua‘a is 
depicted in Figure 5-2.
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19 The University of Maryland found that the health care system (i.e., Medicare) saves about $27,000/year for 
each person who has had a kidney transplant rather than receiving kidney dialysis.  The fiscal transplant-dialysis 
break-even point in 1998 was 2.7 years (Schweitzer, et al., 1998).
 If we overlay the social determinants of health model upon the ahupua‘a system, then 
we can imagine that, like water, resources flow from the mountains (mauka) to the ocean 
(makai).  Similarly, “root causes [upstream] are socio-economic, political and other factors 
that influence living conditions and social circumstances that support or impede health [and 
affect outcomes downstream]” ("Chronic Disease Summit 2011:  Social Determinants of 
Health," 2011).  Please see Figure 5-3 for a visual representation of this concept.
Figure 5-2.  Native Hawaiian ahupua‘a ("Ahupua`a," 2011)
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 If we look broadly at the nation’s health care system, we see that the federal policies 
and resources that sit upstream greatly impact the social determinants of health “in the 
valley” and the resulting effects/outcomes downstream.  Within the context of 
Source: Developed and created by the Chronic Disease Management and Control Branch, 
Hawai'i State Department of Health, February 2011.
Figure 5-3.  The social determinants of health represented in an ahupua‘a framework
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organ donation and transplantation, the goals of the six proposed recommendations are to 
create and enable upstream conditions that can neutralize the barriers (social determinants) to 
graft success, availability of organs for transplantation, efficient use of fiscal resources for 
organ failure, and transplant recipient health in a sustainable, whole-picture approach to 
health care.
 For any of these recommendations to be implemented, the findings of this study must 
be known to and understood by all the relevant stakeholders.  Therefore, I propose to write 
peer-reviewed articles and make presentations at appropriate meetings to reach researchers 
and educators.  I also will write op-ed pieces and may speak at other meetings to reach 
policymakers, practitioners, and transplant recipients and their families.
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Appendix A: Definitions of Terms
(Barnes, Bloom, & Nahin, 2009)
Demographic Terms
Age—The age recorded for each person is the age at his or her last birthday. 
Education—The categories of education are based on the years of school completed or 
highest degree obtained. Only years completed in a school that advances a person toward an 
elementary or high school diploma, General Educational Development high school 
equivalency diploma (GED), college, university, or professional degree are included. 
Health insurance coverage—[R]espondents were asked about their health insurance 
coverage at the time of the interview. 
Hispanic or Latino origin— Hispanic or Latino origin includes persons of Mexican, Puerto 
Rican, Cuban, Central and South American, or Spanish origins. Persons of Hispanic or 
Latino origin may be of any race. 
Marital status—Respondents were asked to choose a marital status category most 
appropriate for their marital situation. In some cases, persons reporting their marital status as 
‘‘married’’ may have been living in common-law marital unions. 
Alternatively, these individuals could have identified their marital status as ‘‘living with 
partner.’’ Adults who were living with a partner were considered to be members of the same 
family (as if married) and are categorized as ‘‘cohabiting.’’ The distinction between 
‘‘married’’ and ‘‘living with partner’’ was made by the respondent. 
Race—The 1997 Office of Management and Budget (OMB) federal guidelines (46) for 
reporting race require that persons of ‘‘single race’’ be distinguished from persons of 
‘‘multiple race.’’ ‘‘Single race’’ refers to persons who indicated only a single race group. 
Estimates for the smaller subcategories of single race persons and multiple race combinations 
can only be reported to the extent that the estimates meet the requirements for confidentiality 
and statistical reliability. In this report, five categories are shown for single race individuals 
(white, black or African American, American Indian or Alaska Native, Asian, and Native 
Hawaiian or Other Pacific Islander). Other subcategories of single race persons and multiple 
race persons are not shown due to statistical unreliability as measured by the relative standard 
errors of the estimates. In this report, persons of a given race may be either Hispanic or non-
Hispanic. 
The text in this report uses shorter versions of the new OMB race terms for conciseness and 
the tables use the complete terms. For example, the category ‘‘black or African American, 
single race’’ in the tables are referred to as ‘‘black’’ in the text. 
Region—In the geographic classification of the U.S. population, states are grouped into four 
regions used by the U.S. Census Bureau: 
Region States include: 
Northeast  Maine, Vermont, New Hampshire, Massachusetts, Connecticut, Rhode 
Island, New York, New Jersey, and Pennsylvania; 
Midwest  Ohio, Illinois, Indiana, Michigan, Wisconsin, Minnesota, Iowa, Missouri, 
North Dakota, South Dakota, Kansas, and Nebraska; 
South   Delaware, Maryland, District of Columbia, West Virginia, Virginia, 
Kentucky, Tennessee, North Carolina, South Carolina, Georgia, Florida, 
Alabama, Mississippi, Louisiana, Oklahoma, Arkansas, and Texas; and
West  Washington, Oregon, California, Nevada, New Mexico, Arizona, Idaho, 
Utah, Colorado, Montana, Wyoming, Alaska, and Hawaii. 
Terms Related to Complementary and Alternative Medicine
Acupuncture—Acupuncture describes a family of procedures involving stimulation of 
anatomical points on the body by a variety of techniques. American practices of acupuncture 
incorporate medical traditions from China, Japan, Korea, and other countries. The 
acupuncture technique that has been most studied scientifically involves penetrating the skin 
with thin, solid, metallic needles that are manipulated by the hands or by electrical 
stimulation. 
Alexander technique—Alexander technique is a movement therapy that uses guidance and 
education on ways to improve posture and movement. The intent is to teach a person how to 
use muscles more efficiently in order to improve the overall functioning of the body. 
Examples of the Alexander technique as CAM are using it to treat low-back pain and the 
symptoms of Parkinson’s disease. 
Alternative provider or practitioner—Someone who is knowledgeable about a specific 
alternative health practice. This person provides care or gives advice about its use, and 
usually receives payment for his or her services. 
For some practices, the provider may have received formalized training and has been 
certified by a licensing board or related professional association. For example, a practitioner 
of biofeedback (biofeedback therapist) usually has received training in psychology and 
physiology and may be certified by the Biofeedback Certification Institute of America. 
Atkins diet—This diet emphasizes a drastic reduction in the daily intake of carbohydrates 
(40 grams or less), countered by an increase in protein and fat. 
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Ayurveda—Ayurveda is a system of medicine that originated in India several thousand years 
ago. In the United States, Ayurveda is considered a type of CAM and a whole medical 
system. As with other such systems, it is based on theories of health and illness and on ways 
to prevent, manage, or treat health problems. Ayurveda aims to integrate and balance the 
body, mind, and spirit (thus, some view it as ‘‘holistic’’). This balance is believed to lead to 
contentment and health and to help prevent illness. However, Ayurveda also proposes 
treatments for specific health problems, whether they are physical or mental. A chief aim of 
Ayurvedic practices is to cleanse the body of substances that can cause disease, and this is 
believed to help reestablish harmony and balance. 
Biofeedback—Biofeedback uses simple electronic devices to teach clients how to 
consciously regulate bodily functions, such as breathing, heart rate, and blood pressure, in 
order to improve overall health. Biofeedback is used to reduce stress, eliminate headaches, 
recondition injured muscles, control asthmatic attacks, and relieve pain. 
Botanica—A Botanica is a traditional healer who supplies healing products, sometimes 
associated with spiritual interventions. 
Chelation therapy—Chelation therapy is a chemical process in which a substance is used to 
bind molecules, such as metals or minerals, and hold them tightly so that they can be 
removed from a system, such as the body. In medicine, chelation has been scientifically 
proven to rid the body of excess or toxic metals. For example, a person who has lead 
poisoning may be given chelation therapy in order to bind and remove excess lead from the 
body before it can cause damage. 
Chiropractic care—This care involves the adjustment of the spine and joints to influence 
the body’s nervous system and natural defense mechanisms to alleviate pain and improve 
general health. It is primarily used to treat back problems, headaches, nerve inflammation, 
muscle spasms, and other injuries and traumas. 
Chiropractic manipulation— Chiropractic manipulation is a form of health care that 
focuses on the relationship between the body’s structure, primarily of the spine, and function. 
Doctors of chiropractic, who are also called chiropractors or chiropractic physicians, use a 
type of hands-on therapy called manipulation (or adjustment) as their core clinical procedure. 
Complementary and alternative medicine (CAM)—Refers to therapies not usually taught 
in U.S. medical schools or generally available in U.S. hospitals. They include a broad range 
of practices and beliefs such as acupuncture, chiropractic care, relaxation techniques, 
massage therapy, and herbal remedies. They are defined by the National Center for 
Complementary and Alternative Medicine as a group of diverse medical and health care 
systems, practices, and products that are not presently considered to be part of conventional 
medicine. 
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Curandero—A Curandero is a type of traditional folk healer. Originally found in Latin 
America, Curanderos specialize in treating illness through the use of supernatural forces, 
herbal remedies, and other natural medicines. 
Deep breathing—Deep breathing involves slow and deep inhalation through the nose, 
usually to a count of 10, followed by slow and complete exhalation for a similar count. The 
process may be repeated 5 to 10 times, several times a day. 
Energy healing therapy—Energy healing therapy involves the channeling of healing energy 
through the hands of a practitioner into the client’s body to restore a normal energy balance 
and, therefore, health. Energy healing therapy has been used to treat a wide variety of 
ailments and health problems, and is often used in conjunction with other alternative and 
conventional medical treatments. 
Espiritista—An Espiritista is a traditional healer who assesses a patient’s condition and 
recommends herbs or religious amulets in order to improve physical or mental health or to 
help overcome a personal problem. 
Feldenkreis—Feldenkreis is a movement therapy that uses a method of education in physical 
coordination and movement. Practitioners use verbal guidance and light touch to teach the 
method through one-on-one lessons and group classes. The intent is to help the person 
become more aware of how the body moves through space and to improve physical 
functioning. 
Guided imagery—Guided imagery involves a series of relaxation techniques followed by 
the visualization of detailed images, usually calm and peaceful in nature. If used for 
treatment, the individual will visualize their body free of the specific problem or condition. 
Sessions are typically 20–30 minutes in length, and may be practiced several times a week. 
Hierbero—A Hierbero or Yerbera is a traditional healer or practitioner with knowledge of 
the medicinal qualities of plants. 
Homeopathy—Homeopathy is a system of medical practices based on the theory that any 
substance that can produce symptoms of disease or illness in a healthy person can cure those 
symptoms in a sick person. For example, someone suffering from insomnia may be given a 
homeopathic dose of coffee. Administered in diluted form, homeopathic remedies are derived 
from many natural sources—including plants, metals, and minerals. 
Hypnosis—Hypnosis is an altered state of consciousness characterized by increased 
responsiveness to suggestion. The hypnotic state is attained by first relaxing the body, then 
shifting attention toward a narrow range of objects or ideas as suggested by the hypnotist or 
hypnotherapist. The procedure is used to effect positive changes and to treat numerous health 
conditions including ulcers, chronic pain, respiratory ailments, stress, and headaches. 
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Macrobiotic diet—A macrobiotic diet is low in fat, emphasizes whole grains and vegetables, 
and restricts the intake of fluids. Of particular importance is the consumption of fresh, 
nonprocessed foods. 
Massage—Massage therapists manipulate muscle and connective tissue to enhance function 
of those tissues and promote relaxation and well-being. 
Meditation—Meditation refers to a group of techniques, most of which started in Eastern 
religious or spiritual traditions. In meditation, a person learns to focus his attention and 
suspend the stream of thoughts that normally occupy the mind. This practice is believed to 
result in a state of greater physical relaxation, mental calmness, and psychological balance. 
Practicing meditation can change how a person relates to the flow of emotions and thoughts 
in the mind. 
Native American Healer or Medicine Man—A Native American Healer or Medicine Man 
is a traditional healer who uses information from the ‘‘spirit world’’ in order to benefit the 
community. People see Native American healers for a variety of reasons, especially to find 
relief or a cure from illness or to find spiritual guidance. 
Naturopathy—Naturopathy is an alternative medical system. Naturopathic medicine 
proposes that there is a healing power in the body that establishes, maintains, and restores 
health. Practitioners work with the patient with a goal of supporting this power through 
treatments such as nutrition and lifestyle counseling, dietary supplements, medicinal plants, 
exercise, homeopathy, and treatments from traditional Chinese medicine. 
Nonvitamin, nonmineral, natural products—Nonvitamin, nonmineral, natural products are 
taken by mouth and contain a dietary ingredient intended to supplement the diet other than 
vitamins and minerals. Examples include herbs or herbal medicine (as single herbs or 
mixtures), other botanical products such as soy or flax products, and dietary substances such 
as enzymes and glandulars.  Among the most popular are echinacea, ginkgo biloba, ginseng, 
feverfew, garlic, kava kava, and saw palmetto. Garlic, for example, has been used to treat 
fevers, sore throats, digestive ailments, hardening of the arteries, and other health problems 
and conditions. 
Ornish diet—The Ornish diet is a high fiber, low-fat, vegetarian diet that promotes weight 
loss and health by controlling what one eats, not by restricting the intake of calories. Fruits, 
beans, grains, and vegetables can be eaten at all meals, while nonfat dairy products such as 
skim milk, nonfat cheeses, and egg whites are to be consumed in moderation. Products such 
as oils, avocados, nuts and seeds, and meats of all kinds are avoided. 
Osteopathic manipulation— Osteopathic manipulation is a full-body system of hands-on 
techniques to alleviate pain, restore function, and promote health and well-being. 
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Pilates—Pilates is a movement therapy that uses a method of physical exercise to strengthen 
and build control of muscles, especially those used for posture. Awareness of breathing and 
precise control of movements are integral components of Pilates. Special equipment, if 
available, is often used. 
Pritikin diet—While meat is allowed, the Pritikin diet (or Pritikin Principle) is low-fat and 
emphasizes the consumption of foods with a large volume of fiber and water, including many 
vegetables, fruits, beans, and natural, unprocessed grains. 
Progressive relaxation—Progressive relaxation is used to relieve tension and stress by 
systematically tensing and relaxing successive muscle groups. 
Qi gong—Qi gong is an ancient Chinese discipline combining the use of gentle physical 
movements, mental focus, and deep breathing directed toward specific parts of the body. 
Performed in repetitions, the exercises are normally performed two or more times a week for 
30 minutes at a time. 
Reiki—Reiki is an energy medicine practice that originated in Japan. In Reiki, the 
practitioner places his hands on or near the person receiving treatment, with the intent to 
transmit ki, believed to be life-force energy. 
Shaman—A Shaman is a traditional healer who is said to act as a medium between the 
invisible spiritual world and the physical world. Most gain knowledge through contact with 
the spiritual world and use the information to perform tasks such as divination, influencing 
natural events, and healing the sick or injured. 
Sobador—A Sobador is a traditional healer who uses massage and rub techniques in order to 
treat patients. 
South Beach diet—South Beach diet distinguishes between ‘‘good’’ and ‘‘bad’’ 
carbohydrates and fats. ‘‘Good’’ carbohydrates are those that are digested relatively slowly, 
and ‘‘bad’’ fats include saturated and trans fats. Although the program does not require one to 
count calories or limit portions, dieters are encouraged to eat whole grain foods and an 
abundant amount of vegetables. 
Tai chi—Tai chi is a mind-body practice that originated in China as a martial art. A person 
doing tai chi moves his body slowly and gently, while breathing deeply and meditating (tai 
chi is sometimes called ‘‘moving meditation’’). Many practitioners believe that tai chi helps 
the flow throughout the body of a proposed vital energy called ‘‘qi.’’ A person practicing tai 
chi moves her body in a slow, relaxed, and graceful series of movements. One can practice 
on one’s own or in a group. The movements make up what are called forms (or routines). 
Traditional healer—A Traditional healer is someone who employs any one of a number of 
ancient medical practices that are based on indigenous theories, beliefs, and experiences 
handed down from generation to generation. The methods employed by each type of 
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Traditional healer have evolved to reflect the different philosophical backgrounds and 
cultural origins of the healer. 
Trager Psychophysical Integration —Trager Psychophysical Integration is a movement 
therapy in which practitioners apply a series of gentle, rhythmic rocking movements to the 
joints. They also teach physical and mental self-care exercises to reinforce the proper 
movement of the body. The intent is to release physical tension and increase the body’s range 
of motion. An example of Trager Psychophysical Integration as CAM is using it to treat 
chronic headaches. 
Vegetarian diets—Vegetarian diets are those totally devoid of meat, red or white. There are, 
however, numerous variations on the nonmeat theme. For example, some vegetarian diets are 
restricted to plant products only, while others may include eggs and dairy products. Another 
variation limits consumption to raw fruit, sometimes supplemented with nuts and vegetables. 
Finally, a number of vegetarian diets prohibit alcohol, sugar, caffeine, or processed foods. a 
practitioner with knowledge of the medicinal qualities of plants. 
Yoga—Yoga combines breathing exercises, physical postures, and meditation to calm the 
nervous system and balance body, mind, and spirit. Usually performed in classes, sessions 
are conducted once a week or more and roughly last 45 minutes. 
Zone diet—With the Zone diet, each meal consists of a small amount of low-fat protein, fats, 
and fiber-rich fruits and vegetables. The basic goal is to alter the body’s metabolism by 
controlling the production of key hormones.
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Appendix B: Survey Instrument
DEPARTMENT OF HEALTH POLICY
AND MANAGEMENT
1101 MCGAVRAN-GREENBERG HALL T   919.966.7350
CAMPUS BOX 7411 F   919.966.6961
CHAPEL HILL, 27599-7411 www.sph.unc.edu/hpm
PEGGY LEATT, PhD
Chair
LAUREL FILES, PhD, MBA
Associate Chair
Dear Recipient:
Thank you for considering participating in this survey, which is part of my dissertation 
research and will help improve transplant recipient care.  I am a doctoral candidate at the 
University of North Carolina at Chapel Hill and a 2002 kidney transplant recipient from a 
deceased donor.   
Transplant recipients represent a population of those who use and seek health treatment and 
therapies.  This survey examines the use of complementary and alternative medicine by solid 
organ transplant recipients in the United States.  In general, survey findings result in new 
information that may help people in the future.  Your participation in this survey will help 
identify new knowledge about our population’s use and opinions on health care.  Your 
information is important and valued.  
You are invited for participation in this study because you are a member of a transplant 
community (local or online) and at least 18 years old.  Participation is totally voluntary, and 
you may leave the survey site at any time.  
Some of these questions may require you to recall things from over the last year, and your 
patience in finishing the survey is greatly appreciated.  The survey has three sections and 
should take about thirty minutes to complete.  Note: once you start the survey, you cannot 
save it and finish it later. 
By clicking on “Enter”, you agree to participate in this study.  Your anonymous answers are 
completely confidential, and the the project’s statistician and I are the only persons with 
access to the data.  No identifying information is requested (e.g., you will not be asked for 
your name, birthdate or the like), and only aggregate (total) findings will be made public in 
my dissertation, presentations, and published materials. 
There are no significant risks to you or benefits for you by participating in this research.  
Indirect benefits include your being a part of increasing knowledge about recipient use of 
complementary and alternative therapies.  There is no cost for you to participate in the study, 
but those who complete the survey, check off the box, and leave their email address will be 
entered to win an iPod shuffle (value: $59) or a $50 Target store gift certificate.
At the end of the survey, you will see results from a 2005 survey I conducted on the 
transplant community’s responses to ethical issues related to organ donation and 
transplantation.  Thank you to those who participated in that survey.
It is your right to contact me with any questions you have about this research at (808) 
551-8838 or by email (rwong@unc.edu).   Your rights are protected by a committee that 
oversees research involving human subjects.  If you have questions or concerns about your 
rights as a research subject you may contact—anonymously if you wish—the Institutional 
Review Board at 919-966-3113 or by email to IRB_subjects@unc.edu.  You may also contact 
my faculty advisor, Ned Brooks, DrPH, MBA, at 919-843-4846 or brookse@email.unc.edu.
Again, thank you very much for helping me with this study.   My hope is that your sharing of 
your experiences and opinions will inform policy recommendations that will improve care 
for all of us.
Rachael Wong, MPH
Honolulu, HI
ENTER
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PART I     This first section contains question about you.  The following questions are 
for classification purposes only, are confidential, and will be kept entirely confidential.
About You 
Q1. TxRec
 I am a transplant recipient who has received at least one (1) solid organ: *   
 1 = Yes
 2 = No
[IF NO] This survey is only for people who have received life-saving solid organ 
transplants.  Thank you for your interest, but we are unable to include you in this 
survey.  [End Survey]
Q1a. NumbTx
 [IF YES] I have had the following number of transplant surgeries: *
1 = 1
2 = 2
3 = 3
4 = 4
5 = 5
6 = 6
Q1b. Organ(s) received in first surgery:
0 = null
1 = Specified organ
• OneKid
• OneKidPanc
• OneHt
• OneHtLg
• OneLvr
• OnePanc
• OneDoubLung
• OneSingLung
• OneInt
Q1b. Organ(s) received in second surgery:
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• TwoKid
• TwoKidPanc
• TwoHt
• TwoHtLg
• TwoLvr
• TwoPanc
• TwoDoubLung
• TwoSingLung
• TwoInt
Q1b. Organ(s) received in third surgery:
• ThreeKid
• ThreeKidPanc
• ThreeHt
• ThreeHtLg
• ThreeLvr
• ThreePanc
• ThreeDoubLung
• ThreeSingLung
• ThreeInt
Q1b. Organ(s) received in fourth surgery:
• FourKid
• FourKidPanc
• FourHt
• FourHtLg
• FourLvr
• FourPanc
• FourDoubLung
• FourSingLung
• FourInt
Q1b. Organ(s) received in fifth surgery:
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• FiveKid
• FiveKidPanc
• FiveHt
• FiveHtLg
• FiveLvr
• FivePanc
• FiveDoubLung
• FiveSingLung
• FiveInt
Q1b. Organ(s) received in sixth surgery:
• SixKid
• SixKidPanc
• SixHt
• SixHtLg
• SixLvr
• SixPanc
• SixDoubLung
• SixSingLung
• SixInt
Q1c. DateTx
 Date of most recent transplant: *
Open-ended text
Q1d. Donor
 Donor (in most recent transplant): *
1 = Living
2 = Deceased
3 = I don’t know
Q1e. KnowDonor
 [IF LIVING] Do you know your donor?
1 = Yes
 2 = No
Q2. Gender
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 Your gender: *
1 = Female
 2 = Male
Q3. OfAge
 Are you 18 years of age or older? *
1 = Yes
 2 = No
Q3a. Age
 Your age today (in years): *
1 = 18 21 = 38 41 = 58 61 = 78
2 = 19 22 = 39 42 = 59 62 = 79
3 = 20 23 = 40 43 = 60 63 = 80
4 = 21 24 = 41 44 = 61 64 = 81
5 = 22 25 = 42 45 = 62 65 = 82
6 = 23 26 = 43 46 = 63 66 = 83
7 = 24 27 = 44 47 = 64 67 = 84
8 = 25 28 = 45 48 = 65 68 = 85
9 = 26 29 = 46 49 = 66 69 = 86
10 = 27 30 = 47 50 = 67 70 = 87
11 = 28 31 = 48 51 = 68 71 = 88
12 = 29 32 = 49 52 = 69 72 = 89
13 = 30 33 = 50 53 = 70 73 = 90
14 = 31 34 = 51 54 = 71 74 = 91
15 = 32 35 = 52 55 = 72 75 = 92
16 = 33 36 = 53 56 = 73 76 = 93
17 = 34 37 = 54 57 = 74 77 = 94
18 = 35 38 = 55 58 = 75 78 = 95
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19 = 36 39 = 56 59 = 76 79 = 96
20 = 37 40 = 57 60 = 77 80 = 97
Q4. Marital
 Your marital status: *
1 = Single   4 = Living with partner
2 = Married   5 = Widowed
3 = Divorced
Q5. Eductn
 The highest level of education you’ve completed: * 
1 = Less than high school  4 = Some college
2 = Some high school   5 = College degree
3 = High school/GED   6 = Graduate degree
Q6. Race
 Your race (choose only one, please): *
1 = Caucasian (white) 
2 = Latino
3 = African-American (black)
4 = Native American (Indian) 
5 = Alaska Native 
6 = Native Hawaiian
7 = Guamanian
8 = Samoan
9 = Other Pacific Islander
10 = Asian Indian
11 = Chinese
12 = Filipino
13 = Japanese
14 = Korean
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15 = Vietnamese
16 = Other Asian
17 = Other
Q6. RaceOther
[Open-ended text]
Q7. Income
 What was your annual household income before taxes in 2009? *
1 = Less than $10,000    4 = $70,000 to under $100,000
2 = $10,000 to under $50,000   5 = $100,000 or more
3 = $50,000 to under $70,000  
Q8. Health
 In general, how would you rate your own health right now? *
1 = Excellent
2 = Very Good
3 = Mostly Good
4 = Good
5 = Fair
6 = Challenging
7 = Poor
Q8. HealthOther
[Open-ended text]
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Q9. Insurance
 Do you have health insurance coverage right now? * 
1 = Yes
 2 = No
Q9a. [IF YES] My insurance coverage is (select as many as apply): *  
Q9a. InsurPriv
 Private
0 = Null
 1 = Private
Q9a. InsurPub
 Public
0 = Null
 1 = Public
Q9a. InsurText
[Open-ended text]
NEW FIELD:
InsurCode
0 = None
1 = Private  (if any private insurance is held)
2 = Public (if only a govt-run plan, inc. military and Tricare)
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Q10. State
 What is your 5-digit zip code? *
[Open-ended text]
NEW FIELD:
StateCode
1 - 51 
NEW FIELD:
Region
1 = Northeast
2 - Midwest
3 = South
4 = West
State Abbr Region State Abbr Region
1 ALABAMA AL 3 27 MONTANA MT 4
2 ALASKA AK 4 28 NEBRASKA NE 2
3 ARIZONA AZ 4 29 NEVADA NV 4
4 ARKANSAS AR 3 30 NEW HAMPSHIRE NH 1
5 CALIFORNIA CA 4 31 NEW JERSEY NJ 1
6 COLORADO CO 4 32 NEW MEXICO NM 4
7 CONNECTICUT CT 1 33 NEW YORK NY 1
8 DELAWARE DE 3 34 NORTH CAROLINA NC 3
9 DISTRICT OF COLUMBIA DC 3 35 NORTH DAKOTA ND 2
10 FLORIDA FL 3 36 OHIO OH 2
11 GEORGIA GA 3 37 OKLAHOMA OK 3
12 HAWAII HI 4 38 OREGON OR 4
13 IDAHO ID 4 39 PENNSYLVANIA PA 1
14 ILLINOIS IL 2 40 RHODE ISLAND RI 1
15 INDIANA IN 2 41 SOUTH CAROLINA SC 3
16 IOWA IQ 2 42 SOUTH DAKOTA SD 2
17 KANSAS KS 2 43 TENNESSEE TN 3
18 KENTUCKY KY 3 44 TEXAS TX 3
19 LOUISIANA LA 3 45 UTAH UT 4
20 MAINE ME 1 46 VERMONT VT 1
21 MARYLAND MD 3 47 VIRGINIA VA 3
22 MASSACHUSETTS MA 1 48 WASHINGTON WA 4
23 MICHIGAN MI 2 49 WEST VIRGINIA WV 3
24 MINNESOTA MN 2 50 WISCONSIN WI 2
25 MISSISSIPPI MS 3 51 WYOMING WY 4
26 MISSOURI MO 2
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PART II   This second section will ask you to recall what kinds, if any, 
complementary and alternative medicine therapies for which you have seen 
practitioners or done on your own in the last 12 months.  
Health Services
Q11. Which of the following CAM (complementary and alternative medicine) therapies 
have you EVER seen a provider/practitioner for yourself OR practiced for yourself?  
*  
0 = Null
1 = Yes
AcuEver - Acupuncture  
AyurEver - Ayurveda
HomeoEver - Homeopathic treatment
NaturoEver - Naturopathy
TradEver - Traditional healer
ChelEver - Chelation Therapy
FolkEver - Folk medicine
DietEver - Diets (e.g., vegetarian, Macrobiotic, Atkins, Ornish, Zone, South 
Beach, etc.) for two weeks or more for health reasons
ChiroEver - Chiropractic care
OsteoEver - Osteopathic manipulation
MassEver - Massage
MovtEver - Movement Therapies like Feldenkries, Alexander Technique, 
Pilates, Trager Psychophysical Integration, etc.
BioEver - Biofeedback
MediEver - Meditation
ImagEver - Guided Imagery
RelaxEver - Progressive Relaxation
BreathEver - Deep breathing exercises
HypnoEver - Hypnosis
YogaEver - Yoga
TaiEver - Tai Chi
QiEver - Qi Gong (chee-KUNG) 
EnergyEver - Energy Healing Therapy/Reiki 
StressEver - Stress management class
SpptEver - Support group meeting
NeverEver - I have never used CAM therapies. 
OtherEver - Other therapy/therapies
OtherEverText
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[Open-ended text]
Q12. DURING THE PAST 12 MONTHS, did you see a provider for, take a class in, or 
practice the following therapy (or therapies)? *
0 = Null
1 = Yes
AcuYear - Acupuncture  
AyurYear - Ayurveda
HomeoYear - Homeopathic treatment
NaturoYear - Naturopathy
TradYear - Traditional healer
ChelYear - Chelation Therapy
FolkYear - Folk medicine
DietYear - Diets (e.g., vegetarian, Macrobiotic, Atkins, Ornish, Zone, South 
Beach, etc.) for two weeks or more for health reasons
ChiroYear - Chiropractic care
OsteoYear - Osteopathic manipulation
MassYear - Massage
MovtYear - Movement Therapies like Feldenkries, Alexander Technique, 
Pilates, Trager Psychophysical Integration, etc.
BioYear - Biofeedback
MediYear - Meditation
ImagYear - Guided Imagery
RelaxYear - Progressive Relaxation
BreathYear - Deep breathing exercises
HypnoYear - Hypnosis
YogaYear - Yoga
TaiYear - Tai Chi
QiYear - Qi Gong (chee-KUNG) 
EnergyYear - Energy Healing Therapy/Reiki 
StressYear - Stress management class
SpptYear - Support group meeting
NeverYear - I have never used CAM therapies. 
OtherYear - Other therapy/therapies
OtherYearText
[Open-ended text]
[Respondents who answer YES to any of the above therapies will be guided—using a skip 
pattern—to Questions 2a-8 for each identified therapy.]
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Q12a. TimesYear = AcuTimes...
 DURING THE LAST 12 MONTHS, how many times did you see a provider for, take 
a class in, or practice [identified therapy]?  
1 = Only one time
2 =  2-5 times
3 =  6-10 times
4 = 11-15 times
5 =  More than 20 times
6 =  Don’t know
Q13. CostTher = AcuCost...
 How much did you spend each time you saw a provider for, took a class in, or 
practiced [identified therapy]?  
1 =   $0-$30
2 =  $31-$100
3 =  $101-$250
4 =  $251-$499
5 =  $500 or more
Q14. Did you use [identified therapy] for any of the following reasons?  Please mark 
each with YES / NO / Don’t Know
1 = Yes
 2 = No
 3 = Don’t know
Q14. ImprEnerTher = AcuEnergy...
To improve or enhance energy
Q14. WellnessTher = AcuWell...
For general wellness or general disease prevention
Q14. ImmuneTher = AcuImmu...
To improve or enhance immune function
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Q14. MedNotHelpTher = AcuMed...
Because medical treatments did not help
Q14. TooExpTher = AcuExp...
Because medical treatments were too expensive
Q14. DrRecTher = AcuDr...
It was recommended by a health care provider
Q14. FrdRecTher = AcuFrd...
It was recommended by family, friends or co-workers
Q14. OtherTher = AcuOther...
Other
Q14a. [OtherTherapies]  
Q14a.  OtherTherOne = AcuOtherOne...   [Open-ended text]
Q14a.  OtherTherTwo = AcuOtherTwo…   [Open-ended text]
Q14a.  OtherTherThree = AcuOtherThree...    [Open-ended text]
Q14a.  OtherTherFour = AcuOtherFour…  [Open-ended text]
Q14a.  OtherTherFive = AcuOtherFive…   [Open-ended text]
Q15. During the LAST 12 MONTHS, which therapies did you use for specific health 
problems or conditions? *
0 = Null
1 = Yes
AcuProb - Acupuncture  
AyurProb - Ayurveda
HomeoProb - Homeopathic treatment
NaturoProb - Naturopathy
TradProb - Traditional healer
ChelProb - Chelation Therapy
FolkProb - Folk medicine
DietProb - Diets (e.g., vegetarian, Macrobiotic, Atkins, Ornish, Zone, South 
Beach, etc.) for two weeks or more for health reasons
ChiroProb - Chiropractic care
OsteoProb - Osteopathic manipulation
MassProb - Massage
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MovtProb - Movement Therapies like Feldenkries, Alexander Technique, 
Pilates, Trager Psychophysical Integration, etc.
BioProb - Biofeedback
MediProb - Meditation
ImagProb - Guided Imagery
RelaxProb - Progressive Relaxation
BreathProb - Deep breathing exercises
HypnoProb - Hypnosis
YogaProb - Yoga
TaiProb - Tai Chi
QiProb - Qi Gong (chee-KUNG) 
EnergyProb - Energy Healing Therapy/Reiki 
StressProb - Stress management class
SpptProb - Support group meeting
NeverProb - I have never used CAM therapies. 
OtherProb - Other therapy/therapies
OtherProbText
[Open-ended text]
Q15a. AcuMain...
What was the MAIN reason for using [identified therapy]?  
1 = Acid   Acid reflux or heartburn   
2 = Angina  Angina   
3 = Anxiety   Anxiety   
4 = Asthma  Asthma   
5 = Arthritis  Arthritis   
6 = ADD  Attention Deficit Disorder/Hyperactivity   
7 = Autism  Autism   
8 = BackPain  Back pain or problem   
9 = BenignTumor Benign tumors, cysts   
10 = Bipolar  Bipolar Disorder   
11 = BirthDef  Birth defect   
12 = Cancer  Cancer   
13 = Chol  Cholesterol   
14 = Bronch  Chronic Bronchitis   
15 = Circuln  Circulation problems (other than in the legs)   
16 = Constpn  Constipation severe enough to require medication   
17 = CoroHtDis Coronary heart disease  
18 = Dementia Dementia, including Alzheimer's Disease   
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19 = DentalPain Dental pain   
20 = Deprssn  Depression   
21 = Diabetes  Diabetes   
22 = Emphysema Emphysema   
23 = Sleepiness Excessive sleepiness during the day   
24 = AlcoTobacco Excessive use of alcohol or tobacco   
25 = Fibro  Fibromyalgia   
26 = Fracture  Fracture, bone/joint injury   
27 = Gout  Gout   
28 = GumDis  Gum disease   
29 = GYN  Gynecologic problem   
30 = HayFvr  Hay fever   
31 = Cold  Head or chest cold   
32 = Hearing  Hearing problem   
33 = HtAttack  Heart attack   
34 = OtherHt  Other heart condition or disease   
35 = Hernia  Hernia   
36 = Hypertensn Hypertension   
37 = InflamBwl Inflammatory bowel disease  
38 = Flu/Pneu  Influenza (flu) or pneumonia   
39 = Insomnia  nsomnia or trouble sleeping   
40 = IBS  Irritable bowel   
41 = Jaw  Jaw pain   
42 = Joint  Joint pain or stiffness/other joint condition   
43 = Knee  Knee problems (not arthritis, not joint injury)  
44 = Liver  Liver problem   
45 = Lung/Breath Lung/breathing problem (not already listed)   
46 = Lupus  Lupus  
47 = Mania  Mania or psychosis   
48 = Memory  Memory loss or loss of other cognitive function   
49 = Menopause Menopause   
50 = Menstrual Menstrual problems   
51 = MentalRet Mental retardation   
52 = Amuptat  Missing limbs (fingers, toes or digits), amputee   
53 = Neck  Neck pain or problem   
54 = Osteoporo Osteoporosis, tendinitis   
55 = Devtal  Other developmental problem   
56 = OtherInjury Other injury   
57 = OtherNerve Other nerve damage, including carpal tunnel syndrome   
58 = Phobia  Phobia or fears   
59 = PolioParaly  Polio (myelitis), paralysis, paraplegia or quadriplegia   
60 = PoorCirc  Poor circulation in legs   
61 = Prostate  Prostate trouble or impotence   
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62 = Headache Regular headaches   
63 = RheumArth Rheumatoid arthritis   
64 = Schizo  Schizophrenia   
65 = Seizure  Seizures   
66 = Senility  Senility   
67 = Migraine  Severe headache or migraine   
68 = Sinusitis    Sinusitis
69 = Skin  Skin problems   
70 = Sprain  Sprain or strain   
71 = GI  Stomach or intestinal illness   
72 = Stroke  Stroke   
73 = SubAbuse Substance abuse, other than alcohol or tobacco   
74 = Ulcer     Ulcer
75 = Urinary  Urinary problem   
76 = Varicose   Varicose veins, hemorrhoids   
77 = Vision  Vision problem   
78 = Kidneys  Weak or failing kidneys   
79 = Weight  Weight problem   
80 = DontKnow Don't know   
81 = OtherWhy Other
Q15a. MainProbText
[Open-ended text]
Q15b. AcuWhyOne, AcuWhyTwo, AcuWhyThree...
 What were the other reasons for using [identified therapy]? [Please select as many as 
apply.]
0 = null
1 = Specified reason
1 = Acid   Acid reflux or heartburn    
2 = Angina  Angina   
3 = Anxiety   Anxiety   
4 = Asthma  Asthma   
5 = Arthritis  Arthritis   
6 = ADD  Attention Deficit Disorder/Hyperactivity   
7 = Autism  Autism   
8 = BackPain  Back pain or problem   
9 = BenignTumor Benign tumors, cysts   
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10 = Bipolar  Bipolar Disorder   
11 = BirthDef  Birth defect   
12 = Cancer  Cancer   
13 = Chol  Cholesterol   
14 = Bronch  Chronic Bronchitis   
15 = Circuln  Circulation problems (other than in the legs)   
16 = Constpn  Constipation severe enough to require medication   
17 = CoroHtDis Coronary heart disease  
18 = Dementia Dementia, including Alzheimer's Disease   
19 = DentalPain Dental pain   
20 = Deprssn  Depression   
21 = Diabetes  Diabetes   
22 = Emphysema Emphysema   
23 = Sleepiness Excessive sleepiness during the day   
24 = AlcoTobacco Excessive use of alcohol or tobacco   
25 = Fibro  Fibromyalgia   
26 = Fracture  Fracture, bone/joint injury   
27 = Gout  Gout   
28 = GumDis  Gum disease   
29 = GYN  Gynecologic problem   
30 = HayFvr  Hay fever   
31 = Cold  Head or chest cold   
32 = Hearing  Hearing problem   
33 = HtAttack  Heart attack   
34 = OtherHt  Other heart condition or disease   
35 = Hernia  Hernia   
36 = Hypertensn Hypertension   
37 = InflamBwl Inflammatory bowel disease  
38 = FluPneu  Influenza (flu) or pneumonia   
39 = Insomnia  Insomnia or trouble sleeping   
40 = IBS  Irritable bowel   
41 = Jaw  Jaw pain   
42 = Joint  Joint pain or stiffness/other joint condition   
43 = Knee  Knee problems (not arthritis, not joint injury)  
44 = Liver  Liver problem   
45 = Lung  Lung/breathing problem (not already listed)   
46 = Lupus  Lupus  
47 = Mania  Mania or psychosis   
48 = Memory  Memory loss or loss of other cognitive function   
49 = Menopause Menopause   
50 = Menstrual Menstrual problems   
51 = MentalRet Mental retardation   
52 = Amputat  Missing limbs (fingers, toes or digits), amputee   
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53 = Neck  Neck pain or problem   
54 = Osteoporo Osteoporosis, tendinitis   
55 = Devtal  Other developmental problem   
56 = OtherInj  Other injury   
57 = OtherNerve Other nerve damage, including carpal tunnel syndrome   
58 = Phobia  Phobia or fears   
59 = PolioParaly  Polio (myelitis), paralysis, paraplegia or quadriplegia   
60 = PoorCirc  Poor circulation in legs   
61 = Prostate  Prostate trouble or impotence   
62 = Headache Regular headaches   
63 = RheumArth Rheumatoid arthritis   
64 = Schizo  Schizophrenia   
65 = Seizure  Seizures   
66 = Senility  Senility   
67 = Migraine  Severe headache or migraine   
68 = Sinusitis    Sinusitis
69 = Skin  Skin problems   
70 = Sprain  Sprain or strain   
71 = GI  Stomach or intestinal illness   
72 = Stroke  Stroke   
73 = SubAbuse Substance abuse, other than alcohol or tobacco   
74 = Ulcer     Ulcer
75 = Urinary  Urinary problem   
76 = Varicose   Varicose veins, hemorrhoids   
77 = Vision  Vision problem   
78 = Kidney  Weak or failing kidneys   
79 = Weight  Weight problem   
80 = DontKnow Don't know   
81 = OtherReason Other
Q15c. AcuWhyText
 Is there anything you’d like to add about why you used [identified therapy]?  
[Open-ended text]
Q16. AcuEff...
 Did you have side effects from [identified therapy]]?  
1 = No
2 = Yes
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Q16. AcuEffText...
[Open-ended text]
Q17. AcuBene...
Was there an improvement (i.e., did you benefit) from [identified therapy]]? 
1 = No
2 = Yes
Q17. AcuBeneText...
[Open-ended text]
Q18. Did you let any of these CONVENTIONAL medical professionals know about your 
use of [identified therapy]? *
1 = Yes
2 = No
3 = Don’t know
4 = NA
Q18. AcuTellMD  Medical doctor (MD, including specialists)
Q18. AcuTellDO  Doctor of osteopathy (D.O.)
Q18. AcuTellNP  Nurse practitioner/Physician assistant
Q18. AcuTellPsych  Psychiatrist
Q18. AcuTellDDS  Dentist
Q18. AcuTellSW  Psychologist/social worker
Q18. AcuTellPharm  Pharmacist
Q18. AcuTellOther  Other
Q19. SupEver
 Have you EVER taken any nonvitamin, nonmineral, natural products (e.g., herbal 
medicines, health supplements/powders)? *
1 = Yes
2 = No
3 = Don’t know
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Q19a. What nonvitamin, nonmineral, natural products have you taken? 
Q19a. SupOne  [Open-ended text]
Q19a. SupTwo  [Open-ended text]
Q19a. SupThree  [Open-ended text]
Q19a. SupFour  [Open-ended text]
Q19a. SupFive  [Open-ended text]
Q19a. SupSix   [Open-ended text]
Q19a. SupSeven  [Open-ended text]
Q19a. SupEight  [Open-ended text]
Q19a. SupNine  [Open-ended text]
Q19a. SupTen  [Open-ended text]
Q19a. SupElev  [Open-ended text]
Q19a. SupTwel  [Open-ended text]
Q19a. SupThirt  [Open-ended text]
Q19a. SupFourt  [Open-ended text]
Q19a. SupFift  [Open-ended text]
Q19a. SupSixt  [Open-ended text]
Q19a. SupSevent  [Open-ended text]
Q19a. SupEighteen  [Open-ended text]
Q19a. SupNinet  [Open-ended text]
Q19a. SupTwenty  [Open-ended text]
Q20. CostSup
How much did you spend on nonvitamin, nonmineral, natural products (e.g., herbal 
medicines, health supplements/powders) in the last 12 months? *
1 =  $0-$30
2 =  $31-$100 
3 =  $101-$250
4 =  $251-$499
5 = $500 or more
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Q21. Did you take nonvitamin, nonmineral, natural products for any of the following 
reasons?  Please mark each with Yes, No, or Don’t know.
1 = Yes
2 = No
3 = Don’t know
Q21. WellnessSup  
For general wellness or general disease prevention
Q21. RxTooExpSup  
Prescription or over-the counter drugs are too expensive
Q21. CureSup 
To treat or cure a specific disease or health problem
Q21. PhysPerfSup  
To improve physical performance
Q21. SportPerfSup 
To improve sports performance
Q21. ImmuneSup  
To improve immune system function
Q21. SexualSup  
To improve sexual performance
Q21. MentalSup  
To improve mental ability or memory
Q21. MedTxNotHelpSup 
Because medical treatments did not help
Q21. MedTooExpSup 
Because medical treatments were too expensive
Q21. MDRecSup 
It was recommended by a health care provider
Q21. FrdRecSup 
It was recommended by family, friends or co-workers
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Q21. OtherWhySup 
Other
Q68. What are the “Other” reasons for using nonvitamin, nonmineral, natural 
products? 
Q21a. OtherWhySupOne 
Q21a. OtherWhySupTwo 
Q21a. OtherWhySupThree 
Q21a. OtherWhySupFour 
Q21a. OtherWhySupFive 
Q22. Did you let any of these CONVENTIONAL medical professionals know about your 
use of nonvitamin, nonmineral, natural products? *
1 = Yes
2 = No
3 = Don’t know
4 = NA
Q22. TellMDSup
Medical doctor (MD, including specialists)
Q21. TellDOSup
Doctor of osteopathy (D.O.)
Q21. TellNPSup
Nurse practitioner/Physician assistant
Q21. TellPsychSup
Psychiatrist
Q21. TellDDSSup
Dentist
Q21. TellSWSup
Psychologist/social worker
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Q21. TellPharmSup
Pharmacist
Q21. TellOtherSup
Other
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PART III      This short final section will ask about your preferences related to 
integrative health care, which combines CAM with conventional medicine.
Integrative Health Care
Integrative health care blends the best of complementary and alternative medicine (CAM) 
and modern medicine into a holistic practice. It is the provision of care that reaffirms the 
importance of the relationship between practitioner and patient, focuses on the whole person, 
is informed by evidence, and makes use of all appropriate therapeutic approaches, health care 
professionals, and disciplines to achieve optimal health and healing.
Q23.  NowIntegrator
 Does someone (inc. yourself) currently integrate/facilitate the combining of your 
conventional and non-conventional care? *
1 = Yes
2 = No
Q23a. Please rank each person who helps facilitate your integrative care in order of her/his 
involvement. You need only rank as many as apply, and if no one helps you then 
please mark "No one". *
1 = First
2 = Second
3 = Third
4 = Fourth
5 = Fifth
Q23a. NowMD
Medical doctor 
Q23a. NowRN
Nurse
Q23a. NowRD
Dietician/Nutritionist
Q23a. NowCAM
Alternative provider(e.g., chiropractor, naturopath)
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Q23a. NowMe
I do it myself 
Q23a. NowNoOne
No One
Q23a. NowOther
Other
Q23b. NowOtherText
 If you ranked "Other", who is "Other"?
[Open-ended text]
Q23c. NowMoreIHC
 Do any of the people you selected lead to your increased use of integrative health 
care? *
1 = Yes
2 = No
Q24. WantIntegrator
 Would you want someone who knows about both conventional medicine and non-
conventional practice to serve as an integrator for your care? *
1 = Yes
2 = No
Q24a. [IF YES] Would you want this integrator to be any of the following (please rank up to 
top five, only as many as apply):
1 = First
2 = Second
3 = Third
4 = Fourth
5 = Fifth
WantPsych  Psychologist/Social worker 
WantPharm  Pharmacist
WantRD  Dietician/Nutritionist
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WantDO  Doctor of Osteopathy (D.O.)
WantMD  Medical doctor (MD, including specialists and 
   psychiatrists)
WantPA Physician Assistant (PA), Nurse (RN), or Nurse practitioner 
(NP)
WantDDS  Dentist
WantCAM   Alternative provider like an acupuncturist or chiropractor)
WantIHC A trained integrator who has knowledge of conventional and 
complementary therapies
WantMe  Me
WantElse  Someone else
Q24b. WantElseText
 If you ranked "Someone else", who is "Someone else"?
[Open-ended text]
Q24c. WantMoreIHC
Would any of these people serving as “integrators”, who help guide you in combined 
conventional and non-conventional care, lead to your increased use of integrative 
health care? 
1 = Yes
2 = No
3 = Maybe
Q24d. WantMoreText
Please Comment
[Open-ended text]
Q25. Important
 What would be important to you if you were seeing an integrative health care 
provider? *
[Open-ended text]
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Q26. What would be the benefit(s) of integrative health care for you? Select as many 
choices as apply: *
1 = Yes
2 = No
3 = Don’t know
WellbeingIHC  Increase my well-being
SymptomsIHC Decrease my symptoms
SatisfnIHC  Increase my satisfaction with my conventional doctor
LimitnsIHC  Decrease my limitations
ControlIHC  Increase my control over my care
FrustratnIHC  Decrease my frustration with the health care system
CommunicIHC Increase my communication with my providers
OtherWhyIHC Other
Q26a. OtherWhyIHCText
 What is “Other”? 
[Open-ended text]
Last Thoughts
Q27. LastText
Finally, is there anything else you would like to share about complementary/
alternative/integrative therapies, the health care system, your experiences, 
recommendations or other?  Your opinions and experiences are valued and 
appreciated.  Please feel free to write in the box below:
[Open-ended text]
Thank you for completing this survey! Your sharing of your experiences, needs, and opinions 
are greatly appreciated. If you would like to be entered to win an iPod shuffle (value: $59) or 
a $50 Target store gift certificate or a copy of the findings, please click HERE.
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Appendix C: Recruitment Materials
Email Request to Transplant Center Administrators:
To:  [Transplant Center administrator]
From: Rachael Wong, MPH
Date:
Subject:  Healthcare survey for solid organ transplant recipients
Aloha,
I am a candidate in the Executive Doctoral Program in Health Leadership at the University of 
North Carolina at Chapel Hill, as well as a kidney transplant recipient from a deceased donor 
(2002).  I am writing to request your assistance in recruiting subjects for my research in 
examining the use of complementary and alternative medicine by solid organ transplant 
recipients in the United States.  Data will be collected through an online survey, and results 
will be made public.
Please help me by forwarding the following email text and attached flyer to your local 
transplant recipients and transplant groups.  Posting it in your clinic will also be appreciated.  
I have also sent this request to organ procurement organizations (OPOs).
There are no significant risks to your patients for participating in this research, and indirect 
benefits include increasing knowledge about recipient use of complementary and alternative 
therapies. 
Note:  In order to minimize selection bias, potential subjects will NOT be told of the research 
subject in this initial request for participation.  You will see on the attached flyer that 
recipients are asked to participate in an online survey of their health care experiences and 
needs.  Thank you in advance for not forwarding this email text to them.  The research topic 
will be disclosed in the online consent form.
I have served on the OPTN/UNOS Transplant Administrators Committee and appreciate all 
you and your staff do to care for transplant donors, candidates, recipients and their loved 
ones.  My hope is that findings from this study will help you in providing the best care for 
your patients and families.
Please contact me if you have questions or need more information.  I can be reached at: 
rwong@unc.edu or 808-551-8838.  You may also contact my faculty advisor, Ned Brooks, 
DrPH, MBA, at 919-843-4846 or brookse@email.unc.edu.
Thank you in advance for your consideration of this request.
Email for transplant administrators to forward to potential participants:
Subject:  Transplant recipient seeks your expertise!
Dear [Name of transplant community],
Rachael Wong, a kidney transplant recipient (from a deceased donor in 2002), is doing 
research on transplant recipients’ health care experiences and needs.  She is a doctoral 
candidate at the University of North Carolina at Chapel Hill.
If you are a solid organ transplant recipient, please help her by completing an online survey.  
Your participation will help inform policy recommendation to improve post-transplant care.  
Women and minorities are strongly encouraged to participate.
Please go to this TxSurvey.questionpro.com and complete the survey by 9/19/10. 
Questions?  Please contact Rachael at: rwong@unc.edu.  You may also contact her faculty 
advisor, Ned Brooks, DrPH, MBA, at 919-843-4846 or brookse@email.unc.edu.
Please forward this email to fellow recipients.  The attached flyer can be posted at meetings 
and distributed to recipients.
Sincerely,
[Name]
(Attachment)
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Email Request to Organ Procurement Organizations:
To:  [Organ Procurement Organization head]
From: Rachael Wong, MPH
Date:
Subject:  Healthcare survey for solid organ transplant recipients
Aloha,
I am a candidate in the Executive Doctoral Program in Health Leadership at the University of 
North Carolina at Chapel Hill, as well as a kidney transplant recipient from a deceased donor 
(2002).  I am writing to request your assistance in recruiting subjects for my research in 
examining the use of complementary and alternative medicine by solid organ transplant 
recipients in the United States.  Data will be collected through an online survey, and results 
will be made public.
Please help me by forwarding the following email text and attached flyer to your local 
transplant recipients and transplant groups.   I have also sent this request to transplant 
centers.
Note:  In order to minimize selection bias, potential subjects will NOT be told of the research 
subject in this initial request for participation.  You will see on the attached flyer that 
recipients are asked to participate in an online survey of their health care experiences and 
needs.  Thank you in advance for not forwarding this email text to them.  The research topic 
will be disclosed in the online consent form.
I have served on the OPTN/UNOS Transplant Administrators Committee and have had the 
opportunity to work with great OPO leaders.  I also sit on the board of our local OPO and 
appreciate all you and your staff do to care for donor families and increase the availability of 
organs and tissue for transplantation.
Please contact me if you have questions or need more information.  I can be reached at: 
rwong@unc.edu or 808-551-8838.  You may also contact my faculty advisor, Ned Brooks, 
DrPH, MBA, at 919-843-4846 or brookse@email.unc.edu
Thank you in advance for your consideration of this request,
Rachael Wong
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Email for organ procurement organizations to forward to potential participants:
Subject:  Transplant recipient seeks your expertise!
Dear [Name of transplant community],
Rachael Wong, a kidney transplant recipient (from a deceased donor in 2002), is doing 
research on transplant recipients’ health care experiences and needs.  She is a doctoral 
candidate at the University of North Carolina at Chapel Hill.
If you are a solid organ transplant recipient, please help her by completing an online survey.  
Your participation will help inform policy recommendation to improve post-transplant care.  
Women and minorities are strongly encouraged to participate.
Please go to this TxSurvey.questionpro.com and complete the survey by 9/19/10. 
All participants who complete the survey will have a chance to win an iPod shuffle or a 
Target store gift certificate.
Questions?  Please contact Rachael at: rwong@unc.edu.  You may also contact her faculty 
advisor, Ned Brooks, DrPH, MBA, at 919-843-4846 or brookse@email.unc.edu.
Please forward this email to fellow recipients.  The attached flyer can be posted at meetings 
and distributed to recipients.
Sincerely,
[Name]
(Attachment)
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Recruitment flyer sent as attachment:
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Text for posting on transplant listservs and online bulletin boards:
Subject/New Thread:  Transplant recipient seeks your expertise!
Aloha!
My name is Rachael Wong.  I am a kidney transplant recipient (from a deceased donor in 
2002) and am doing research on transplant recipients’ health care experiences and needs as a 
doctoral candidate at the University of North Carolina at Chapel Hill.
I am posting this request for your assistance.  If you are a solid organ transplant recipient, 
please help me by completing an online survey.  Your participation will help inform policy 
recommendation to improve post-transplant care.  Women and minorities are strongly 
encouraged to participate.
Please go to this TxSurvey.questionpro.com and complete the survey by 9/19/10. 
All participants who complete the survey will have a chance to win an iPod shuffle or a 
Target store gift certificate.
Questions?  Please contact me at: rwong@unc.edu.  You may also contact my faculty advisor, 
Ned Brooks, DrPH, MBA, at 919-843-4846 or brookse@email.unc.edu.
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Email request to people in local, regional and national transplant groups:
To:  [transplant contact]
From: Rachael Wong, MPH
Date:
Subject:  Transplant recipient seeks other recipients’ expertise!
Aloha!
My name is Rachael Wong.  I am a kidney transplant recipient (from a deceased donor in 
2002) and am doing research on transplant recipients’ health care experiences and needs as a 
doctoral candidate at the University of North Carolina at Chapel Hill.
I writing to ask for your assistance.  Please forward this email request to those in your 
transplant community and on your transplant distribution list.  My goal is for as many solid 
organ transplant recipients in the United States to learn about this study as possible.
If you are a solid organ transplant recipient, please help me by completing an online survey.  
Your participation will help inform policy recommendation to improve post-transplant care.  
Women and minorities are strongly encouraged to participate.
Please go to this TxSurvey.questionpro.com and complete the survey by 9/19/10. 
All participants who complete the survey will have a chance to win an iPod shuffle or 
a Target store gift certificate.
Questions?  Please contact me at: rwong@unc.edu.  You may also contact my faculty advisor, 
Ned Brooks, DrPH, MBA, at 919-843-4846 or brookse@email.unc.edu.
Thank you in advance for helping me with my research.  I appreciate your forwarding this 
email request to others in our transplant community.
With gratitude,
Rachael
(Attachment)
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Follow-up email to transplant centers and organ procurement organizations:
To:  [Transplant Center administrator/Organ Procurement Organization head]
From: Rachael Wong, MPH
Date:
Subject:  Transplant recipient STILL seeks your expertise!
Thank for you for your assistance with this research on transplant recipients’ health care 
experiences.  Please forward this one-time follow-up request for participation in my study to 
your local transplant recipients and transplant groups.  Thank you in advance.
Aloha!
Thank you to everyone who took the time and completed the online survey that is part of my 
dissertation research.  I really appreciate your sharing of your experiences and opinions.  
Thank you very much.
If you haven’t completed the survey, I am writing to ask you to consider participating in this 
study that will provide new knowledge on transplant recipients’ experiences in health care.
The survey is only open through 9/19/10!  Please go to this TxSurvey.questionpro.com and 
complete the survey by 9/19/10. 
All participants who complete the survey will have a chance to win an iPod shuffle or a 
Target store gift certificate.
Questions?  Please contact me at: rwong@unc.edu.  You may also contact my faculty advisor, 
Ned Brooks, DrPH, MBA, at 919-843-4846 or brookse@email.unc.edu.
With thanks,
Rachael
I am a kidney transplant recipient (from a deceased donor in 2002) and am doing research on transplant 
recipients’ health care experiences and needs as a doctoral candidate at the University of North Carolina at 
Chapel Hill.
136
Follow-up posting for transplant listservs and online bulletin boards:
Subject/New Thread:  Transplant recipient STILL seeks your expertise!
Aloha!
Thank you to everyone who took the time and completed the online survey that is part of my 
dissertation research.  I really appreciate your sharing of your experiences and opinions.  
Thank you very much.
If you haven’t completed the survey, I am writing to ask you to consider participating in this 
study that will provide new knowledge on transplant recipients’ experiences in health care.
The survey is only open through 9/19/10!  Please go to this TxSurvey.questionpro.com and 
complete the survey by 9/19/10. 
All participants who complete the survey will have a chance to win an iPod shuffle or a 
Target store gift certificate.
Questions?  Please contact me at: rwong@unc.edu.  You may also contact my faculty advisor, 
Ned Brooks, DrPH, MBA, at 919-843-4846 or brookse@email.unc.edu.
With thanks,
Rachael
I am a kidney transplant recipient (from a deceased donor in 2002) and am doing research on transplant 
recipients’ health care experiences and needs as a doctoral candidate at the University of North Carolina at 
Chapel Hill.
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Appendix D: Joint Principles of Patient-Centered Medical Homes
(Patient-Centered Primary Care Collaborative, 2007)
Introduction
The Patient Centered Medical Home (PCMH) is an approach to providing comprehensive 
primary care for children, youth and adults. The PCMH is a health care setting that 
facilitates partnerships between individual patients, and their personal physicians, and 
when appropriate, the patient’s family.
The AAP, AAFP, ACP, and AOA, representing approximately 333,000 physicians, have 
developed the following joint principles to describe the characteristics of the PC-MH.
Principles
• Personal physician - each patient has an ongoing relationship with a personal 
physician trained to provide first contact, continuous and comprehensive care.
• Physician directed medical practice – the personal physician leads a team of 
individuals at the practice level who collectively take responsibility for the ongoing 
care of patients.
• Whole person orientation – the personal physician is responsible for providing for all 
the patient’s health care needs or taking responsibility for appropriately arranging 
care with other qualified professionals. This includes care for all stages of life; acute 
care; chronic care; preventive services; and end of life care.
• Care is coordinated and/or integrated across all elements of the complex health care 
system (e.g., subspecialty care, hospitals, home health agencies, nursing homes) and 
the patient’s community (e.g., family, public and private community-based services). 
Care is facilitated by registries, information technology, health information exchange 
and other means to assure that patients get the indicated care when and where they 
need and want it in a culturally and linguistically appropriate manner.
• Quality and safety are hallmarks of the medical home:
• Practices advocate for their patients to support the attainment of optimal, patient-
centered outcomes that are defined by a care planning process driven by a 
compassionate, robust partnership between physicians, patients, and the patient’s 
family.
• Evidence-based medicine and clinical decision-support tools guide decision 
making
• Physicians in the practice accept accountability for continuous quality 
improvement through voluntary engagement in performance measurement and 
improvement.
• Patients actively participate in decision-making and feedback is sought to ensure 
patients’ expectations are being met
• Information technology is utilized appropriately to support optimal patient care, 
performance measurement, patient education, and enhanced communication
• Practices go through a voluntary recognition process by an appropriate non-
governmental entity to demonstrate that they have the capabilities to provide 
patient centered services consistent with the medical home model.
• Patients and families participate in quality improvement activities at the practice 
level.
• Enhanced access to care is available through systems such as open scheduling, 
expanded hours and new options for communication between patients, their personal 
physician, and practice staff.
• Payment appropriately recognizes the added value provided to patients who have a 
patient-centered medical home. The payment structure should be based on the 
following framework:
• It should reflect the value of physician and non-physician staff patient-centered 
care management work that falls outside of the face-to-face visit.
• It should pay for services associated with coordination of care both within a given 
practice and between consultants, ancillary providers, and community resources.
• It should support adoption and use of health information technology for quality 
improvement;
• It should support provision of enhanced communication access such as secure e-
mail and telephone consultation;
• It should recognize the value of physician work associated with remote 
monitoring of clinical data using technology.
• It should allow for separate fee-for-service payments for face-to-face visits. 
(Payments for care management services that fall outside of the face-to-face visit, 
as described above, should not result in a reduction in the payments for face-to-
face visits).
• It should recognize case mix differences in the patient population being treated 
within the practice.
• It should allow physicians to share in savings from reduced hospitalizations 
associated with physician-guided care management in the office setting.
• It should allow for additional payments for achieving measurable and continuous 
quality improvements.
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Background of the Medical Home Concept
The American Academy of Pediatrics (AAP) introduced the medical home concept in 
1967, initially referring to a central location for archiving a child’s medical record. In 
its 2002 policy statement, the AAP expanded the medical home concept to include 
these operational characteristics:  accessible, continuous, comprehensive, family-
centered, coordinated, compassionate, and culturally effective care.
The American Academy of Family Physicians (AAFP) and the American College of 
Physicians (ACP) have since developed their own models for improving patient care 
called the “medical home” (AAFP, 2004) or “advanced medical home” (ACP, 2006).
For More Information:
American Academy of Family Physicians
http://www.futurefamilymed.org 
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